hg_3876.1

Basic information about the TSS

---

TSS ID: hg_3876.1 Species: human Chr: chr1		Start: 86704858 End: 86704868 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC007455 Distance: -4 GeneID: 51100 HGNC/MGI_ID: HGNC:10833 UniProt_ID:

Gene_name: SH3 domain containing GRB2 like, endophilin B1 Gene_symbol: SH3GLB1 Gene_synonyms: Bif-1 CGI-61 KIAA0491 PPP1R70 Gene_source: HGNC:10833

TATA-Box annotation

---

Distance to TSS:	287
Nearest PromoterID:	NM_016009
Entrez ID:	51100
Nearest Unigene:	Hs.136309
Nearest Refseq:	NM_016009
Nearest Ensembl:	ENSG00000097033
Gene Name:	SH3 domain containing GRB2 like, endophilin B1
Gene Alias:	Bif-1|CGI-61|PPP1R70|dJ612B15.2
Gene Description:	SH3 domain containing GRB2 like, endophilin B1
Gene Type:	protein-coding
CpG%:	0.13
GC%:	0.731343
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SH3GLB1 p2@SH3GLB1 p3@SH3GLB1 p4@SH3GLB1 p5@SH3GLB1 p6@SH3GLB1 p7@SH3GLB1 p8@SH3GLB1 p9@SH3GLB1 p10@SH3GLB1
Sample		p1@SH3GLB1	p2@SH3GLB1	p3@SH3GLB1	p4@SH3GLB1	p5@SH3GLB1	p6@SH3GLB1	p7@SH3GLB1	p8@SH3GLB1	p9@SH3GLB1	p10@SH3GLB1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	24.74	20.65	7.79	1.56	0.00	0.19	0.39	0.78	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.50	16.99	8.09	0.81	0.81	1.01	0.20	0.81	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	30.29	16.40	6.75	2.51	0.96	0.77	0.00	0.77	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	27.03	16.63	6.65	0.83	0.21	0.21	0.21	0.21	0.21	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	26.32	14.85	7.42	1.57	0.90	0.90	0.22	0.45	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.68	16.86	5.62	2.33	0.39	0.19	0.19	0.19	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.31	22.01	11.77	1.53	0.65	0.22	0.44	0.87	0.22	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	28.34	24.22	7.51	1.94	0.00	0.00	0.24	0.00	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.86	23.08	10.47	1.50	0.85	0.64	0.21	0.21	0.00	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	35.94	16.81	3.48	3.48	0.00	0.00	1.16	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	35.98	22.64	6.06	2.43	0.00	0.40	1.21	2.43	0.00	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.28	21.14	8.94	2.85	0.41	0.00	0.00	0.41	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.69	9.03	12.41	0.32	0.32	1.13	0.48	0.00	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.41	5.26	10.52	0.45	0.45	0.75	0.15	0.15	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	30.96	10.76	13.17	1.10	0.88	1.76	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.67	7.29	10.06	0.75	0.75	0.75	0.50	0.25	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	25.99	6.55	8.30	0.00	0.44	1.31	0.22	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.84	3.80	8.01	0.00	0.42	2.11	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.46	3.20	7.46	0.53	0.53	1.60	0.53	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	25.27	5.27	12.19	0.30	0.60	1.05	0.75	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	29.54	4.14	9.49	1.07	0.13	1.34	0.80	0.13	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.72	5.35	7.94	0.52	1.04	1.21	0.69	0.17	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.85	7.76	10.34	0.39	0.65	1.42	0.39	0.00	0.13	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.99	7.28	12.62	0.97	0.24	0.97	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	28.89	9.55	11.61	0.52	0.00	0.52	0.00	0.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.80	5.70	12.34	0.32	0.95	0.95	0.63	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	22.53	4.95	6.59	0.55	0.00	1.65	1.10	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.99	8.96	11.32	0.47	0.47	1.41	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.48	8.24	6.78	0.16	0.65	0.81	0.81	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.14	8.87	12.31	0.36	0.72	0.90	0.00	0.54	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	26.80	6.07	9.00	1.05	0.63	2.30	0.42	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.99	7.03	11.53	0.39	0.78	2.15	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.79	4.22	9.92	0.63	1.06	1.06	0.63	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	28.20	4.62	6.10	0.82	0.66	0.33	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	26.55	7.11	8.23	1.12	0.56	0.93	0.37	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.57	7.28	13.22	0.38	0.57	0.77	0.38	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.75	8.79	10.83	0.82	0.41	1.02	0.41	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.39	9.87	10.88	0.60	1.41	1.61	0.40	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	32.68	10.80	14.05	0.81	0.27	1.89	1.35	0.27	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.85	7.68	14.16	0.72	1.68	1.92	1.20	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.70	6.59	8.47	0.71	1.65	1.18	0.94	0.00	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	31.77	4.39	6.73	0.73	0.88	1.32	0.29	0.59	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	28.89	13.08	14.13	0.63	1.27	2.32	1.05	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.32	11.71	14.51	0.00	0.70	1.75	0.52	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.55	13.45	15.46	1.41	1.00	3.01	1.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.78	9.77	13.03	1.40	1.16	2.79	1.40	0.70	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.51	9.84	14.15	0.72	0.72	2.16	0.48	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.99	12.52	14.90	1.79	2.38	2.09	0.60	0.30	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.81	11.25	15.08	0.96	1.20	2.87	0.00	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	42.87	9.71	13.95	1.01	0.40	2.02	0.81	0.00	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.38	7.58	11.07	0.61	0.82	1.64	1.23	0.82	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	50.03	10.90	15.79	1.56	1.56	2.89	0.67	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	265.85	0.00	0.00	13.99	13.99	0.00	13.99	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	39.39	8.16	15.26	0.00	0.35	1.42	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	38.11	13.92	11.27	1.66	0.99	2.98	1.33	0.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	109.90	5.03	2.52	1.68	4.19	0.84	6.71	0.00	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	65.67	4.13	3.67	1.38	3.21	0.00	1.38	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	47.00	11.34	22.69	0.00	1.62	2.59	0.65	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	40.47	14.13	17.02	0.32	0.96	4.18	0.64	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	64.12	6.92	8.49	0.94	2.20	1.26	0.94	0.63	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	49.35	10.58	16.92	2.12	1.41	0.00	1.41	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	35.89	16.26	16.82	0.56	0.00	2.80	0.00	0.00	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	79.61	7.96	7.17	1.59	3.98	0.80	3.98	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	50.63	6.46	9.85	0.68	0.68	1.02	1.36	0.00	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	42.89	17.22	21.44	0.97	0.65	3.57	0.32	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	46.86	14.91	15.26	0.35	0.35	1.06	0.35	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	533.41	16.16	16.16	0.00	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	379.08	23.69	31.59	0.00	7.90	0.00	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	61.43	13.65	12.19	0.00	0.49	1.46	0.49	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	67.44	14.88	8.93	0.99	0.99	3.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	63.33	9.85	13.14	0.94	0.94	1.41	0.47	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	71.87	6.29	7.29	0.00	1.32	1.99	0.66	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	64.34	11.14	11.75	0.00	0.93	0.93	0.62	0.93	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	71.54	11.62	14.68	0.61	0.00	1.83	0.31	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	110.87	6.49	4.59	1.11	4.28	0.32	0.95	1.11	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	100.27	15.24	6.10	3.05	1.60	0.00	1.93	1.12	0.64	0.64
Adipocyte - omental, donor1	11473-119C6	146.06	13.87	6.23	2.54	2.67	0.25	2.16	1.27	1.02	0.64
Adipocyte - omental, donor2	11474-119C7	82.22	10.46	5.98	1.49	2.24	0.75	2.24	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	108.51	17.08	6.03	1.00	1.67	0.00	1.00	0.33	1.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	107.82	8.29	6.38	0.00	2.55	0.64	0.64	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	91.26	12.09	3.30	2.20	0.00	0.00	0.00	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	95.29	15.81	1.81	3.61	2.26	0.90	1.35	1.35	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	57.52	31.28	10.60	2.78	1.22	0.35	0.35	0.17	0.35	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	129.47	21.90	10.37	2.93	3.32	0.39	0.98	0.78	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	63.06	9.52	5.92	0.51	0.77	0.26	0.77	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	88.37	22.30	9.48	1.67	0.84	0.56	0.84	0.56	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	115.21	18.22	11.76	2.94	1.18	0.00	0.00	1.18	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	222.40	35.79	9.01	5.95	3.14	0.16	1.29	2.17	0.97	2.73
Adipocyte differentiation, day08, donor2	13023-139D8	131.36	26.47	13.56	2.26	0.32	0.32	1.94	0.00	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	108.77	19.73	4.80	2.13	1.07	0.00	1.07	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	151.91	28.38	7.23	3.90	1.11	0.00	1.67	0.56	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	177.59	34.10	6.65	4.57	3.33	0.42	1.25	1.25	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	122.57	24.61	5.53	1.76	0.50	0.25	1.00	1.26	0.50	2.01
Adipocyte differentiation, day12, donor3	13027-139E3	131.23	22.91	6.54	5.56	3.93	0.33	0.33	1.64	0.33	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	151.63	23.44	7.00	2.74	1.52	1.22	0.61	0.91	1.22	1.52
Alveolar Epithelial Cells, donor1	11510-119G7	15.91	5.52	6.19	0.88	0.22	0.44	0.88	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	17.57	4.66	6.45	0.36	0.00	0.36	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	2.40	5.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	27.17	6.66	9.71	0.54	0.18	0.72	0.54	0.36	0.54	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	6.69	5.02	0.00	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.68	5.96	8.42	0.62	0.82	1.44	0.21	0.00	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	87.76	10.30	9.96	1.49	1.03	0.69	0.92	1.03	0.23	0.80
Anulus Pulposus Cell, donor2	11463-119B5	63.92	10.29	11.51	0.73	0.73	0.73	0.24	0.73	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	87.61	8.99	5.84	1.35	1.80	0.90	0.00	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	103.76	14.33	9.12	1.74	1.30	1.30	1.30	0.00	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	92.03	12.84	2.14	0.00	4.28	2.14	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	84.00	9.57	5.68	1.20	0.90	0.00	1.20	0.30	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	80.94	13.91	5.06	2.53	2.53	0.00	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	63.37	6.60	5.28	1.98	0.00	1.32	0.66	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	82.52	7.80	3.25	0.32	1.30	0.00	0.32	0.32	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	72.82	10.68	7.28	2.43	0.00	1.94	0.49	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	76.02	2.97	5.94	0.59	1.19	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	82.11	7.91	4.90	1.51	1.88	0.38	1.13	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	88.53	10.16	5.81	0.73	0.00	0.73	0.00	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	94.03	6.27	2.51	0.00	0.00	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	99.67	6.42	5.44	1.48	0.99	1.32	1.65	0.99	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	84.62	8.19	9.55	1.36	1.36	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	72.08	5.28	5.43	0.75	1.21	1.51	0.75	0.30	0.90	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	76.08	11.79	9.64	2.14	1.61	0.54	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	82.00	9.26	7.37	0.94	1.89	0.57	0.94	0.94	0.57	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	81.52	8.29	5.61	0.80	1.87	1.60	0.00	1.34	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	71.21	12.68	11.71	0.00	0.98	0.00	0.98	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	85.09	10.28	5.14	1.16	1.33	1.49	0.83	0.50	0.66	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	80.45	8.41	3.60	0.00	2.40	0.00	0.00	0.00	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	102.66	10.62	10.62	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	78.05	6.86	7.72	1.54	0.86	1.20	0.69	0.69	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	8.39	0.00	8.39	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	84.46	10.19	8.74	3.40	0.00	0.97	1.46	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	96.76	6.83	5.31	0.38	0.38	0.38	0.00	0.38	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	76.32	7.27	3.63	0.00	1.21	0.00	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	84.37	7.98	7.41	2.85	1.71	1.71	0.57	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	78.67	9.83	5.56	0.64	0.64	0.43	0.64	0.86	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	74.59	6.45	5.68	0.77	1.03	1.55	0.26	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	87.74	7.51	5.16	0.00	1.41	0.00	0.47	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	76.53	9.32	7.07	2.25	1.29	0.00	0.64	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	66.35	7.13	2.14	0.00	0.00	2.14	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	86.57	9.94	6.43	0.58	0.58	0.58	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	84.90	7.23	6.62	0.30	1.20	0.00	0.30	0.30	0.30	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	79.60	13.07	4.75	1.19	1.19	0.00	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	91.03	10.68	3.56	2.03	0.51	0.51	1.02	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	86.34	8.40	6.62	0.25	1.02	0.25	1.53	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	68.62	8.90	5.08	1.91	0.64	1.27	1.27	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	82.85	10.79	4.75	1.73	1.29	1.29	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	76.00	6.56	7.20	1.06	2.12	1.91	0.85	0.42	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	71.63	8.99	4.35	1.45	1.16	1.16	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	84.08	3.78	2.83	0.94	2.83	0.94	1.89	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	71.71	6.95	5.76	0.68	0.68	0.34	0.51	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	69.49	6.95	4.63	0.00	0.00	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	118.30	6.34	4.23	2.11	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	74.83	6.65	6.43	0.43	0.86	1.07	0.21	0.21	0.64	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	64.38	10.83	4.81	1.80	0.60	0.00	0.00	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	72.17	6.56	8.02	0.73	0.00	2.19	1.46	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	91.03	7.59	6.21	0.69	0.92	0.69	0.92	0.92	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	58.66	12.75	0.00	0.00	5.10	2.55	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	106.27	7.12	4.07	0.76	0.51	1.02	1.02	0.76	0.51	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	94.55	7.64	7.02	0.62	0.21	0.41	0.41	0.41	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	73.75	7.65	7.04	1.84	0.92	0.31	0.31	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	97.99	12.91	6.21	0.48	1.43	0.00	0.48	0.96	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	79.83	7.98	4.43	2.22	1.77	0.89	1.11	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	68.66	0.00	3.05	3.05	1.53	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	81.42	8.31	7.20	2.77	2.22	0.55	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	82.62	7.94	5.30	1.85	1.06	0.00	0.53	0.53	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	79.59	7.63	3.27	1.45	0.36	0.73	0.00	0.73	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	25.55	9.46	11.42	0.37	0.37	0.61	0.25	0.12	0.00	0.25
Astrocyte - cerebellum, donor2	11580-120F5	22.42	15.06	14.04	0.34	0.00	0.86	0.17	0.17	0.00	0.68
Astrocyte - cerebellum, donor3	11661-122F5	11.33	7.97	10.28	0.42	0.21	0.63	0.00	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	41.13	10.46	8.71	1.74	0.70	1.05	0.35	0.00	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	39.15	17.47	13.59	0.49	0.65	1.13	0.49	0.32	0.00	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	37.74	16.11	11.93	1.79	0.75	0.75	0.15	0.45	0.15	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	53.44	11.12	6.54	1.38	1.26	0.69	0.46	0.57	0.46	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	47.11	10.90	8.14	0.88	1.13	1.00	0.75	0.63	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	49.62	9.22	8.19	1.59	1.02	1.02	0.34	0.23	0.11	0.00
Basophils, donor1	12241-129G9	58.32	7.06	4.97	1.31	1.31	0.78	0.78	0.00	1.57	0.26
Basophils, donor2	12242-129H1	119.42	10.82	11.91	0.72	2.53	0.36	3.61	0.72	3.25	0.00
Basophils, donor3	12243-129H2	69.38	10.88	12.05	1.32	2.20	0.73	2.20	0.88	1.62	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	19.84	2.16	4.74	0.00	0.00	0.22	0.00	0.65	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	16.46	0.91	3.66	0.91	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	14.35	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	43.94	3.77	3.77	0.00	1.26	0.63	1.26	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	29.74	4.16	6.03	0.83	0.00	0.42	0.42	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	38.23	5.76	8.75	0.46	0.92	0.46	0.00	0.69	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	46.61	3.42	5.22	0.18	1.08	0.90	0.54	0.90	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	39.26	8.24	9.48	0.41	1.96	0.41	1.44	0.21	0.93	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	47.28	10.48	6.99	0.70	1.86	1.16	0.47	0.47	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	60.76	6.40	11.83	0.32	1.92	0.96	0.96	0.64	1.92	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	10.34	20.68	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	51.85	10.71	8.45	3.38	1.69	1.69	1.13	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	67.56	19.86	17.08	2.23	1.30	0.37	0.56	0.19	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	66.96	26.12	16.68	1.32	0.88	1.32	0.88	0.44	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	116.05	5.66	8.77	2.26	3.40	1.42	1.42	0.85	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	103.87	6.44	9.10	1.52	1.90	0.00	2.27	2.27	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	120.65	10.85	9.20	1.64	2.96	1.97	3.29	0.33	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	127.64	15.03	18.50	1.01	2.75	2.60	2.89	0.43	1.88	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	120.09	15.69	12.07	0.30	1.81	1.51	3.02	0.91	2.11	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	139.53	13.98	17.06	1.66	5.45	3.32	1.66	0.47	2.84	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	104.12	18.41	14.90	1.67	1.34	2.01	1.51	0.33	1.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	86.39	21.53	14.08	1.38	1.93	1.10	1.10	0.00	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	110.58	17.11	14.38	0.25	1.24	0.74	1.24	0.25	2.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	131.58	27.61	20.75	1.37	1.76	2.15	1.37	0.98	1.37	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	111.64	27.60	18.70	1.25	2.14	2.85	1.78	0.53	1.42	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	174.97	24.59	15.89	0.65	3.70	2.18	3.05	0.22	2.83	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	95.76	22.48	18.26	3.98	2.34	1.64	0.94	0.00	1.40	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	109.83	20.07	19.01	3.17	3.17	1.58	0.53	0.00	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	94.30	13.31	9.98	1.11	1.11	1.11	3.33	0.00	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	97.88	13.09	13.09	1.49	1.93	2.83	2.08	0.74	1.93	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	85.41	9.18	9.98	1.60	2.39	1.40	1.40	0.00	0.60	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	112.84	8.95	8.74	0.42	3.75	1.25	3.54	0.42	3.33	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	92.66	15.33	15.10	0.69	0.92	1.14	3.20	0.23	1.37	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	78.95	11.08	7.69	1.81	1.81	0.90	3.39	0.23	2.04	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	82.93	9.60	8.73	0.87	2.18	1.31	2.18	0.44	2.62	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	135.30	22.06	24.75	1.61	4.30	3.50	2.69	0.81	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	140.61	28.09	21.81	1.74	5.23	3.31	2.62	0.70	2.27	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	186.84	20.62	22.30	1.26	4.21	3.79	2.95	0.00	2.95	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	108.94	24.07	17.09	1.65	1.65	2.57	1.47	0.55	1.84	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	100.04	19.02	14.80	0.35	0.70	1.06	2.82	0.00	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	99.15	20.18	13.60	0.88	1.32	2.63	0.88	0.44	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	120.49	30.17	21.27	1.92	0.70	2.09	1.74	0.35	1.57	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	93.29	20.07	18.96	2.97	1.12	1.49	1.12	0.37	0.74	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	171.58	20.91	14.87	2.59	2.59	2.59	3.23	0.43	4.53	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	113.84	22.52	23.34	2.05	2.05	2.87	0.41	0.41	1.23	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	85.07	12.05	12.52	1.16	1.39	0.23	2.09	0.46	2.55	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	115.76	14.15	12.53	1.62	3.94	1.39	2.09	0.46	3.25	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	93.94	4.36	5.89	0.87	1.09	0.87	3.05	0.65	1.96	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	89.86	7.16	11.32	1.62	2.31	1.15	2.54	0.46	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	100.08	6.28	5.85	2.17	1.73	1.52	2.82	0.22	1.08	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	119.91	12.61	13.24	1.40	2.80	1.56	2.96	0.31	2.18	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	98.32	12.40	9.26	0.87	3.67	1.22	3.84	0.17	1.05	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	143.82	12.26	10.93	1.56	4.91	1.11	3.57	0.45	3.57	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	91.10	6.38	8.42	1.28	1.53	1.02	2.30	0.26	2.81	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	95.29	9.00	12.08	0.88	1.98	0.88	2.20	0.22	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	95.80	8.84	7.37	0.84	2.74	0.63	2.74	1.47	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	8.13	2.03	4.06	2.03	2.03	2.03	0.00	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	86.78	11.53	11.53	0.00	2.71	0.00	0.68	0.68	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	76.63	8.28	3.11	0.00	2.07	0.00	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	76.22	11.19	13.33	1.07	1.60	0.53	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	87.92	8.04	7.50	0.54	3.75	0.00	3.22	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	86.34	11.93	4.91	1.40	4.91	0.00	3.51	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	65.89	15.69	3.92	0.00	3.92	0.00	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	96.23	17.14	9.23	1.32	6.59	1.32	1.32	0.00	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	43.56	26.30	7.40	0.82	2.47	0.82	1.64	0.00	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	45.70	15.96	7.98	1.45	4.35	0.00	0.00	0.00	2.18	0.00
CD19+ B Cells, donor3	11705-123B4	40.39	19.18	9.59	1.01	1.01	0.00	0.00	0.00	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	60.61	10.10	22.22	0.40	2.02	1.21	1.62	0.81	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	43.94	7.59	13.98	0.80	1.60	2.80	0.40	1.20	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	48.19	15.06	13.05	0.00	2.01	2.01	1.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	113.49	14.61	17.98	1.12	3.37	0.00	1.12	1.12	4.49	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	62.75	5.64	12.02	1.13	2.63	1.13	1.13	0.75	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	70.58	5.41	8.34	0.68	2.25	1.35	0.90	0.23	0.90	0.00
CD4+ T Cells, donor1	11225-116C1	70.34	8.93	26.07	0.71	2.14	2.14	2.14	0.36	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	50.83	13.47	18.98	0.61	0.00	0.61	0.61	0.00	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	63.13	10.67	18.30	1.22	2.13	2.13	1.52	0.30	0.91	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	86.78	4.34	6.89	1.02	1.79	0.51	1.53	0.26	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	90.74	4.27	8.53	0.00	1.80	1.57	1.57	0.67	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	88.83	3.74	6.90	0.29	0.57	2.01	2.30	0.57	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	45.99	6.64	9.48	0.00	0.95	0.00	0.47	0.47	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	37.93	10.53	14.05	2.11	2.11	0.00	0.70	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	9.89	3.30	3.30	0.00	0.00	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	98.99	3.18	8.53	0.29	1.88	0.58	1.45	0.43	0.72	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	97.10	5.08	12.03	0.17	2.03	2.71	1.36	0.34	0.68	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	85.28	4.67	8.71	0.64	1.45	0.97	0.97	1.13	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.00	4.93	14.35	0.45	2.24	1.34	1.34	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	99.23	5.24	13.28	0.35	2.10	1.05	2.10	0.70	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	114.40	1.76	10.56	0.44	3.08	0.44	1.32	0.44	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	83.48	3.37	9.28	0.00	0.84	0.42	1.26	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	69.19	4.36	8.31	0.21	0.83	1.04	3.12	0.42	0.62	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	64.49	4.34	9.36	1.00	1.67	0.33	0.33	0.33	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	62.82	5.71	14.14	0.82	2.45	1.63	1.63	0.00	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	75.57	8.04	15.54	0.54	2.14	1.61	2.14	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	44.83	1.79	5.38	1.79	3.59	1.79	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	104.21	4.08	11.68	0.19	2.78	1.48	0.93	0.19	0.93	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	75.17	3.03	10.18	0.22	1.73	1.73	0.87	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	83.22	4.62	11.77	0.84	2.10	2.10	0.84	0.42	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	76.35	3.54	13.65	0.51	1.52	0.00	2.02	0.00	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	71.05	5.20	19.50	0.87	3.47	0.87	1.73	0.43	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	94.14	6.10	10.46	0.44	3.05	0.87	2.61	0.00	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	91.06	6.93	14.85	0.49	1.98	1.48	1.48	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	86.78	3.69	12.92	0.00	2.77	0.92	3.69	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	82.35	6.98	11.17	1.40	1.40	4.19	0.00	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	105.23	8.03	13.57	0.28	3.32	0.55	2.49	0.28	0.83	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	126.38	8.59	19.39	0.25	4.42	0.74	4.42	0.00	1.96	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	106.26	4.62	6.16	0.00	3.08	0.00	1.54	0.00	4.62	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	113.17	7.52	14.32	0.00	2.51	1.79	3.58	0.00	2.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	98.33	8.31	6.92	1.38	2.77	1.38	0.00	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	99.20	17.02	25.54	0.33	1.64	0.33	1.31	0.65	4.26	0.33
CD8+ T Cells, donor2	11307-117C2	82.22	21.02	28.53	1.50	3.38	1.13	2.63	0.00	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	68.42	20.20	29.29	0.76	2.02	1.51	1.01	0.25	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.42	4.36	2.75	0.23	0.69	0.00	0.23	0.00	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.89	6.95	2.64	0.48	0.48	0.00	0.24	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.78	6.29	1.09	0.27	0.27	0.27	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.72	6.00	3.30	0.30	0.00	0.30	0.30	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	17.04	6.96	1.92	0.00	0.72	0.48	0.48	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.10	5.68	2.73	0.45	0.91	0.23	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	21.51	5.00	2.82	0.00	0.00	0.22	0.22	0.00	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	28.16	6.84	3.95	0.00	0.53	0.26	0.26	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.56	5.39	1.88	0.70	0.70	0.00	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.74	4.23	2.11	0.00	0.30	0.30	0.91	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.37	4.07	1.74	0.58	0.00	0.29	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.05	2.93	2.13	0.27	0.80	0.27	0.27	0.27	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.20	8.76	2.19	0.44	0.44	0.44	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.24	7.74	0.91	0.00	0.46	0.00	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	25.36	14.17	7.46	0.00	0.75	0.00	1.49	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	25.57	6.12	1.44	0.00	0.72	0.36	0.00	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	18.41	7.77	3.74	0.00	0.29	0.29	0.29	0.58	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.80	5.66	2.83	0.24	0.00	0.00	0.00	0.24	0.47	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.45	4.12	1.58	0.00	0.63	0.63	0.95	0.32	0.32	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.99	4.92	2.77	0.62	0.31	0.31	0.62	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.40	5.13	2.89	0.32	0.00	0.96	0.32	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	4.97	3.44	0.00	0.38	0.38	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	7.49	2.76	0.00	0.39	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	6.05	2.27	0.00	0.00	0.00	0.00	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.09	13.65	7.23	0.80	0.00	0.00	0.00	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	28.68	16.09	6.99	0.70	0.00	0.00	0.70	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	18.03	5.01	2.00	1.00	1.00	0.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	144.39	21.93	12.79	3.66	0.00	0.00	1.83	1.83	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	79.55	10.38	5.93	0.49	0.49	1.48	0.99	0.49	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	101.23	16.73	7.89	1.79	1.47	0.63	0.95	1.05	0.84	0.74
Chondrocyte - de diff, donor1	11261-116G1	78.00	12.48	12.83	2.08	1.39	1.73	1.73	1.04	0.00	1.39
Chondrocyte - de diff, donor2	11338-117F6	56.50	6.04	5.69	0.36	2.13	0.00	0.71	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	62.24	7.05	6.03	1.48	1.82	0.57	1.14	0.34	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	115.49	2.69	5.37	1.79	2.69	1.79	1.79	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	62.28	4.04	7.68	0.00	0.40	0.40	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	71.38	16.41	13.89	0.57	1.03	1.49	0.92	0.46	0.46	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	54.30	15.18	12.83	1.92	1.28	1.28	1.28	0.00	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	51.77	12.83	11.59	1.50	1.06	1.86	1.06	0.35	0.35	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	42.46	22.01	29.89	29.25	0.83	4.40	0.92	1.93	0.28	7.89
Corneal Epithelial Cells, donor1	11526-119I5	15.59	2.20	3.51	0.00	0.22	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	22.75	0.00	2.28	0.00	0.00	0.00	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	23.01	3.83	4.60	0.00	0.51	0.26	0.00	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	96.91	3.14	4.79	0.50	2.31	0.99	1.98	0.33	0.99	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	96.52	2.52	3.78	0.32	3.15	1.26	2.84	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	120.77	6.90	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	99.57	2.81	4.00	0.43	2.59	0.97	1.62	0.54	0.65	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	81.31	8.88	19.13	1.71	4.10	0.68	1.71	0.34	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	95.97	4.57	13.06	0.00	4.57	1.31	2.61	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	76.95	5.81	26.62	0.00	2.42	0.48	2.90	0.00	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	98.56	9.34	7.50	0.50	1.33	1.00	0.50	0.67	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	65.72	9.39	4.69	1.17	2.35	2.93	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	87.10	11.31	10.18	0.85	0.28	0.85	0.00	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	112.84	9.83	7.08	0.79	0.00	1.57	0.39	0.39	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	61.67	10.76	7.27	0.29	1.45	0.58	0.58	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	83.29	9.65	9.88	0.71	2.35	1.65	0.24	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	75.56	7.36	6.31	0.35	1.23	0.00	0.88	0.53	0.35	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	123.68	7.98	6.65	0.89	0.66	0.22	0.44	0.66	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	126.58	12.17	5.78	1.22	1.22	1.83	0.30	0.61	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	136.72	9.30	7.33	0.28	1.69	0.00	1.13	0.56	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	60.62	5.05	8.62	0.89	0.59	0.89	0.89	0.89	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	48.94	4.17	2.60	1.04	1.04	0.00	0.52	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	48.35	5.53	6.24	0.71	0.71	0.71	0.28	0.43	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	114.83	7.60	14.40	0.40	1.60	1.60	0.40	1.60	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	50.32	9.96	6.29	1.57	0.52	0.52	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	189.35	15.16	11.06	2.11	1.99	0.99	1.99	0.87	1.12	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	126.88	13.04	10.86	1.09	0.65	1.52	0.22	1.09	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	151.32	17.59	13.56	1.34	0.98	2.08	0.61	1.47	0.00	0.73
Endothelial Cells - Vein, donor1	11267-116G7	40.95	9.10	6.83	0.00	0.00	1.14	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	56.58	6.29	4.19	0.70	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	69.71	9.11	5.97	0.63	0.47	0.63	0.63	0.47	0.31	0.31
Eosinophils, donor1	12244-129H3	167.72	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	316.85	13.20	23.10	4.95	1.65	3.30	6.60	0.00	11.55	0.00
Eosinophils, donor3	12246-129H5	360.25	14.27	17.83	0.00	0.00	0.00	0.00	0.00	0.00	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	18.32	2.20	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	118.64	11.49	9.85	2.05	3.28	0.00	2.05	0.82	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	74.89	14.12	7.77	2.30	2.63	0.44	1.09	0.33	0.55	1.09
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	75.19	22.21	12.89	1.73	1.63	1.52	0.98	0.54	0.54	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	111.33	11.64	7.52	3.64	2.06	0.73	1.46	1.33	0.97	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	103.31	17.74	8.46	3.82	0.96	1.23	2.05	1.91	1.50	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	96.61	12.55	9.60	2.32	1.90	0.95	1.16	0.42	0.74	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	44.00	9.49	8.43	2.63	1.32	1.05	1.84	0.26	0.79	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	91.35	13.29	9.63	1.00	2.33	0.66	0.33	1.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	101.61	21.32	7.26	2.27	3.18	1.36	1.81	1.36	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	47.75	7.58	5.31	0.76	0.00	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	54.10	8.20	5.84	1.10	0.95	0.63	0.79	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	142.76	18.49	9.40	3.64	2.73	0.30	1.21	1.21	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	124.49	19.80	13.96	2.16	2.41	1.14	1.65	0.89	0.25	0.63
Fibroblast - Cardiac, donor6	11460-119B2	116.58	19.10	11.52	1.82	1.52	0.91	1.67	1.06	0.30	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	42.74	8.98	6.70	0.54	0.40	0.40	0.27	0.13	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	74.64	12.08	4.31	2.59	1.73	0.86	0.43	0.43	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	54.20	7.32	11.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	33.44	25.14	15.45	1.15	0.46	1.15	0.00	0.23	0.00	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	111.94	14.42	10.52	2.20	1.70	0.51	1.36	0.51	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	57.05	6.34	5.40	0.94	1.41	0.47	0.70	0.23	0.47	0.70
Fibroblast - Dermal, donor2	11346-117G5	61.32	3.77	6.13	1.89	0.47	0.94	0.00	0.00	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	83.05	9.91	6.65	1.57	1.69	0.60	0.60	1.09	0.48	0.36
Fibroblast - Dermal, donor4	11450-119A1	61.50	18.65	15.15	2.37	0.34	0.90	0.11	0.57	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	78.50	21.63	14.31	1.05	0.52	0.52	0.70	0.70	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	76.18	15.92	13.64	0.49	1.62	1.14	0.97	0.97	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	90.58	6.04	8.95	0.83	0.62	0.83	2.29	1.46	0.42	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	96.42	6.81	14.15	1.83	3.41	0.52	0.79	1.05	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	64.18	10.41	9.62	0.79	1.45	0.92	1.05	0.40	0.26	0.13
Fibroblast - Gingival, donor3	11394-118C8	93.40	19.24	14.60	2.51	1.93	1.55	0.97	1.55	0.19	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	85.19	4.16	6.23	2.08	2.08	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	64.67	10.40	8.11	0.53	1.76	0.53	0.18	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	85.59	9.98	12.00	1.25	3.43	1.56	1.56	0.78	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	91.55	7.57	7.57	1.49	2.70	1.22	1.08	0.54	1.22	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.94	21.88	35.29	1.76	0.71	3.18	0.00	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	103.25	12.14	10.24	1.61	2.34	1.61	1.02	0.73	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	108.40	7.23	8.45	1.77	2.05	1.36	1.09	0.82	1.36	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	90.83	13.93	17.33	1.21	2.19	1.54	0.99	1.10	0.33	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	70.14	9.54	14.53	3.67	2.20	1.17	0.73	0.59	0.59	0.29
Fibroblast - Lung, donor1	11270-116H1	38.06	5.44	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	70.13	10.45	4.48	1.49	0.00	0.00	0.00	0.00	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	46.85	10.55	9.71	0.42	0.21	0.63	1.27	0.21	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	53.31	9.16	6.66	0.00	0.00	0.00	0.83	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	13.99	2.80	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	16.79	5.04	3.36	0.56	0.56	0.00	0.00	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	54.81	12.99	8.53	0.41	1.22	1.22	0.41	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	23.97	7.99	3.99	0.00	0.00	3.99	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	11.91	0.00	0.00	5.96	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	78.56	10.09	10.09	1.94	2.13	0.97	0.78	1.36	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	65.98	18.96	9.86	2.12	1.21	0.76	0.61	0.91	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	108.63	6.12	12.24	1.84	2.45	1.53	1.22	0.61	0.61	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	75.18	8.40	7.63	0.38	2.29	1.14	0.00	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	72.36	9.45	7.29	1.89	2.16	1.35	1.89	1.08	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	66.22	14.15	11.02	1.74	1.16	1.51	0.12	0.23	0.35	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	123.46	12.05	8.29	1.99	2.10	0.99	1.99	0.77	1.44	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	32.51	8.13	6.30	0.20	0.41	1.02	0.00	1.02	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	26.73	8.69	4.68	1.34	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	55.35	7.51	7.12	1.98	0.79	0.40	0.79	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	58.15	12.90	10.91	0.79	0.60	0.99	0.60	0.60	0.99	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	75.84	5.51	6.93	0.71	2.31	0.53	1.07	0.18	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	93.42	6.31	4.73	0.79	2.37	0.20	1.58	0.79	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.62	4.81	10.23	1.20	0.60	0.90	0.90	0.30	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	95.86	9.18	8.74	0.76	4.21	1.40	2.70	0.65	0.86	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	61.50	7.85	9.62	0.76	0.76	0.25	1.77	1.52	1.01	0.25
Fibroblast - skin normal, donor1	11553-120C5	95.66	7.22	8.37	0.82	2.79	0.82	1.48	0.33	0.98	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	57.35	5.61	7.02	1.60	0.60	1.40	1.40	1.20	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	116.13	8.24	11.85	1.11	2.91	1.11	2.61	0.90	0.60	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	59.84	7.86	12.09	0.30	0.30	0.60	1.51	0.30	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	91.63	8.28	8.37	0.75	2.73	0.83	1.49	0.41	0.75	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	97.10	10.60	10.09	0.85	3.59	0.34	1.20	0.68	0.34	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	48.94	8.54	8.21	0.66	0.99	0.33	0.00	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	115.79	7.46	13.53	1.92	2.98	0.32	2.98	1.17	1.38	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	63.59	6.92	8.43	0.34	3.04	1.18	0.67	0.84	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	100.84	5.33	4.86	0.63	3.76	0.47	2.04	0.94	0.31	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	797.75	44.32	66.48	0.00	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.05	6.10	11.33	0.00	0.00	1.74	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	100.55	4.68	5.20	1.56	1.91	1.04	2.43	0.87	1.56	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	98.37	5.47	5.99	1.04	2.60	2.08	2.86	0.26	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	102.21	5.11	8.43	1.28	2.30	1.28	2.04	0.00	1.02	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	25.26	16.08	13.78	5.36	0.00	0.77	1.53	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	18.50	10.21	10.85	3.19	0.00	1.91	0.64	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	22.54	16.83	11.70	2.28	0.00	2.00	0.57	0.00	0.00	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	15.17	29.51	34.75	8.82	0.55	3.03	0.00	0.28	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	17.58	23.75	22.15	6.16	0.46	2.28	0.23	0.46	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	20.01	23.18	24.17	3.57	0.79	2.97	0.00	0.20	0.00	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.54	32.78	30.66	8.46	0.26	0.79	0.53	0.53	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.24	31.96	25.44	7.18	0.00	3.59	0.00	0.00	0.00	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	17.69	15.48	12.38	2.21	0.44	0.00	0.44	0.00	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.47	11.73	4.38	0.57	0.14	0.57	0.14	0.14	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.33	14.04	7.02	0.74	0.37	0.62	0.12	0.00	0.12	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.33	7.79	5.91	0.54	0.27	0.27	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	12.64	15.49	8.18	0.99	0.25	0.37	0.00	0.12	0.12	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	9.41	13.15	7.20	0.97	0.28	0.28	0.14	0.00	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	8.74	8.95	3.66	0.61	0.00	0.61	0.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	17.34	9.81	7.07	0.23	0.68	0.46	0.46	0.00	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	14.08	11.46	6.85	0.75	0.12	0.37	0.00	0.12	0.00	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.45	13.99	7.87	1.75	0.44	0.66	0.00	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	10.05	6.21	5.32	0.30	0.00	0.59	0.00	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.03	11.76	6.04	0.64	0.00	0.95	0.32	0.16	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	16.98	13.63	5.14	1.12	0.45	0.67	0.45	0.45	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.11	8.27	3.43	1.01	0.40	0.40	0.60	0.00	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	15.78	11.87	4.58	0.34	0.85	0.34	0.00	0.51	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.73	10.46	6.30	1.51	0.18	0.80	0.35	0.44	0.18	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.29	12.07	9.68	0.94	0.73	0.52	0.21	0.21	0.21	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.39	10.25	4.78	1.20	0.17	0.34	0.17	0.17	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.04	12.28	4.65	0.66	0.11	0.33	0.33	0.11	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	24.54	8.15	5.57	1.16	0.33	0.75	0.42	0.17	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	19.81	7.35	3.47	0.61	0.20	0.41	0.20	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	18.36	7.22	5.16	0.00	0.41	1.24	0.21	0.21	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	16.60	13.72	6.00	0.69	0.23	0.46	0.12	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.18	8.51	4.84	0.67	0.33	0.67	0.17	0.17	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.08	7.49	5.51	0.44	0.00	0.66	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.02	11.07	5.90	0.74	0.74	0.49	0.25	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.48	8.10	4.38	0.49	0.00	0.32	0.16	0.32	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.96	10.26	5.77	0.96	0.32	0.00	0.32	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	20.47	9.10	5.97	0.66	0.47	0.38	0.09	0.19	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.08	7.12	7.91	0.79	0.63	0.16	0.16	0.79	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	19.16	8.21	6.39	1.22	0.61	0.30	0.00	0.30	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.74	8.47	4.60	1.15	0.42	0.31	0.21	0.10	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.98	7.46	4.61	1.10	0.88	0.44	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	24.69	10.94	5.89	1.40	0.00	0.28	0.28	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.78	8.80	6.94	1.02	0.65	0.28	0.46	0.37	0.19	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	20.86	5.88	4.81	1.07	0.27	0.53	0.80	0.53	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.60	7.65	4.44	1.07	0.61	0.15	0.77	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.79	8.29	5.57	0.78	0.26	0.78	0.00	0.00	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.21	7.86	5.15	0.81	0.27	0.27	0.54	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	34.10	7.01	3.87	1.11	0.37	0.92	0.18	0.18	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.85	7.46	7.02	0.66	0.88	0.22	0.44	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	25.79	13.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.52	6.60	4.75	0.92	0.53	0.53	0.92	0.13	0.40	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	35.91	8.68	5.25	0.81	0.40	0.00	0.40	0.40	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	37.62	8.39	9.15	0.51	1.52	0.51	0.76	0.25	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.36	7.37	7.37	0.80	0.20	0.40	0.20	0.20	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	7.24	10.17	6.47	1.39	0.31	0.62	0.00	0.15	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	8.18	12.48	7.98	0.82	0.00	0.61	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.02	12.20	7.51	0.63	0.00	0.00	0.00	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.02	8.48	7.35	0.85	0.28	1.41	0.00	0.57	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	14.30	15.22	11.07	1.38	0.00	0.46	0.00	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	12.37	4.95	2.47	0.00	2.47	0.00	0.00	4.95	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.30	28.24	6.58	3.48	1.16	1.16	0.00	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	17.65	14.44	0.00	1.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	31.30	13.91	5.22	1.74	1.74	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.71	21.16	8.14	4.23	0.98	1.30	1.30	0.00	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	23.06	20.59	10.71	1.24	0.82	0.82	0.82	0.41	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	29.99	16.66	6.66	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	23.21	20.97	8.39	2.52	0.84	0.84	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.82	26.15	11.11	1.96	0.65	0.98	0.33	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	14.26	31.88	15.10	2.52	0.84	0.84	0.84	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.45	24.49	12.09	2.54	0.64	1.27	0.32	0.00	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	22.08	23.10	6.45	1.36	1.02	1.36	0.68	0.34	0.00	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	18.79	16.71	2.09	0.00	0.00	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.20	26.34	16.61	2.29	0.57	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.09	23.68	9.47	0.89	1.78	0.59	0.30	0.59	0.00	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	44.05	22.02	11.86	0.00	0.00	1.69	0.00	1.69	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.72	23.20	12.43	0.83	0.83	0.83	0.41	0.00	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	23.93	21.40	11.28	2.07	1.15	0.92	0.23	0.92	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	31.61	0.00	0.00	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	24.22	18.84	9.61	2.31	1.54	0.00	0.77	0.38	0.00	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	38.14	21.84	11.41	1.96	0.98	1.30	0.00	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	43.47	37.46	23.41	3.34	0.67	0.00	0.00	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.67	29.28	10.40	3.47	0.77	0.77	0.39	0.00	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	49.30	27.73	10.95	3.42	1.03	0.68	0.68	0.00	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	49.70	9.94	7.45	4.97	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.03	35.86	21.23	3.77	0.47	0.47	0.00	0.47	0.00	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	31.99	8.45	2.41	1.81	1.21	0.00	0.00	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	43.75	17.80	3.56	2.03	0.51	0.51	0.00	0.00	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	28.32	32.70	17.15	3.59	1.60	0.80	0.00	0.00	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	19.73	25.65	14.80	1.48	0.99	0.00	0.49	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	38.95	12.98	1.18	0.00	0.00	0.00	1.18	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.84	24.50	9.92	4.08	0.58	0.58	0.00	1.75	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	36.43	24.14	13.61	3.51	0.88	1.32	0.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.93	39.84	8.48	3.39	0.85	0.85	1.70	0.85	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	33.43	24.47	9.55	1.79	0.00	1.19	0.00	0.00	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.48	13.10	7.28	0.97	1.94	0.00	0.49	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	4.57	1.14	0.00	3.42	1.14	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	44.91	4.99	4.99	1.25	0.83	0.42	0.83	0.83	0.00	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	57.35	5.62	3.37	2.25	1.12	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	52.01	7.29	5.39	0.95	0.95	0.32	0.32	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	40.52	2.09	4.60	0.00	0.84	0.00	1.25	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.64	3.71	5.22	0.46	0.23	0.58	0.58	0.81	0.23	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	42.20	3.54	4.22	0.17	0.34	1.01	0.17	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.71	2.73	3.64	0.68	0.00	2.05	0.23	0.46	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	30.17	2.95	4.26	0.66	0.77	1.20	0.11	0.44	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.10	4.08	3.87	0.21	0.86	1.07	0.21	0.64	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.85	2.15	2.37	0.65	0.86	0.43	0.00	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	33.25	4.11	4.23	0.50	0.87	1.00	0.37	0.62	0.12	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	28.13	2.57	2.74	0.17	0.69	1.37	0.34	0.51	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	26.27	3.20	3.84	0.32	1.28	0.00	0.32	0.32	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	56.52	15.67	12.87	2.24	0.56	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.24	10.39	9.52	0.43	0.87	0.43	0.00	1.30	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	84.60	7.93	7.93	5.29	2.64	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	79.36	35.98	10.23	3.53	0.00	2.82	0.71	0.35	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	37.05	13.08	6.54	2.18	0.00	0.73	1.45	0.00	0.00	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	106.30	22.73	9.62	2.10	1.05	0.35	1.75	1.75	0.17	1.22
Hepatocyte, donor1	11523-119I2	44.79	9.68	3.63	0.00	1.21	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	53.87	10.77	8.62	2.15	5.39	2.15	1.08	0.00	2.15	0.00
Hepatocyte, donor3	11684-122I1	53.38	9.20	6.75	0.61	0.61	1.23	0.61	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	27.41	5.87	8.48	0.00	0.00	0.65	0.00	0.00	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	25.34	5.77	4.89	0.87	0.87	0.17	1.22	0.17	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.31	6.59	8.10	0.41	0.41	1.23	1.23	0.82	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	6.37	6.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	8.31	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	7.51	5.01	0.00	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	7.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	13.71	9.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	12.99	16.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	1.67	6.67	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	10.89	3.63	3.63	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	5.29	7.94	0.00	0.00	1.32	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	3.33	8.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	5.24	5.24	5.24	0.00	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	11.97	9.45	0.63	0.00	1.26	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	6.19	3.09	0.00	0.00	0.00	3.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	5.17	3.88	0.00	0.00	1.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	6.44	9.66	8.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	10.59	13.85	0.00	0.00	4.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.20	3.78	5.04	0.00	0.42	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	6.43	4.82	9.64	0.00	0.00	0.80	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	4.62	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	5.19	8.02	0.47	0.47	2.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	4.53	5.44	0.00	0.00	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	29.48	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	6.46	11.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	7.62	5.08	0.00	0.00	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	5.10	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	7.29	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	3.57	9.28	0.00	0.00	2.14	0.00	0.71	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	9.95	3.32	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.33	5.25	5.56	0.00	0.00	0.93	0.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	1.76	8.78	0.00	0.00	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	6.29	15.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	9.04	6.95	0.00	0.00	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	6.64	13.28	0.00	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	6.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	2.62	4.36	12.21	0.87	0.00	1.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	4.50	4.50	0.00	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	6.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	8.53	5.33	1.07	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	6.93	4.16	0.00	0.00	1.39	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	5.70	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	6.44	6.44	0.00	0.00	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	9.08	12.10	0.00	0.00	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	6.21	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	4.23	10.57	0.00	0.00	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	53.20	4.81	5.71	1.14	0.49	1.31	0.49	0.49	0.08	0.16
Keratinocyte - epidermal, donor2	11349-117G8	15.81	2.93	2.93	0.59	1.17	1.17	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	54.71	6.44	8.71	0.76	0.85	1.42	1.04	0.47	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	74.58	6.92	12.37	0.68	2.27	1.25	0.23	0.34	0.11	0.11
Keratocytes, donor1	11527-119I6	44.01	23.72	11.00	2.41	1.72	0.69	0.34	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	24.61	4.69	10.55	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	51.97	24.90	16.80	2.37	1.19	0.99	0.00	0.20	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	13.19	6.59	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	43.15	2.16	2.16	1.08	2.16	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	58.36	19.84	12.23	1.96	1.04	1.15	0.92	0.81	0.00	0.23
Lens Epithelial Cells, donor3	11690-122I7	95.76	12.31	11.60	1.21	1.82	1.11	1.11	0.81	0.91	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	64.15	6.88	4.98	0.47	0.47	0.83	0.47	0.36	0.12	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	44.09	6.14	6.70	0.00	0.00	0.56	0.56	1.12	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	76.50	6.30	5.35	1.42	0.94	0.79	0.94	0.16	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	48.39	3.23	3.76	1.08	0.54	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	52.32	7.56	6.30	0.63	0.32	0.63	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	39.57	4.31	4.64	0.54	0.86	1.08	0.00	0.11	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	63.61	9.85	6.16	0.41	1.23	1.23	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.53	4.05	4.55	0.25	0.00	1.26	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	40.11	5.63	5.35	0.56	1.13	0.28	0.42	0.28	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	63.68	9.10	5.93	0.40	0.40	0.40	0.40	0.79	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	49.63	5.04	4.85	0.58	0.97	1.16	0.97	0.58	0.39	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.03	3.70	3.15	0.19	0.19	0.19	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	52.61	7.32	3.14	0.35	0.70	0.70	1.05	0.35	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	51.04	5.96	6.20	0.48	0.95	0.00	0.00	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	36.81	5.77	3.85	0.14	0.82	0.41	0.41	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	75.14	6.47	8.01	0.92	1.23	0.62	0.62	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	4.05	4.36	0.62	0.31	0.62	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	38.61	4.94	4.03	0.73	0.55	0.55	0.37	0.55	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	52.66	4.61	8.56	0.33	0.33	0.99	0.33	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	33.68	5.56	3.51	0.29	0.00	0.59	0.29	0.29	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.87	3.98	4.48	1.00	0.50	0.00	0.50	0.50	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	53.83	6.79	4.36	0.00	0.00	0.97	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	47.93	6.73	5.39	0.54	0.27	0.27	0.27	1.08	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	45.87	6.21	6.06	0.15	1.21	0.45	0.61	0.30	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	49.25	8.81	3.11	1.56	1.56	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	63.86	10.68	5.23	1.26	0.42	1.26	0.00	0.00	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	41.20	6.17	4.81	0.15	0.45	0.60	0.60	0.15	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	60.53	4.82	3.44	0.00	0.00	0.00	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	51.93	7.34	6.77	0.38	0.56	0.38	0.19	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.42	4.88	3.18	0.21	0.53	0.11	0.11	0.64	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	69.29	6.30	7.27	0.00	1.45	0.00	0.00	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	38.04	6.95	4.96	1.65	0.33	0.00	0.66	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	31.22	4.96	5.20	0.37	0.25	0.37	0.12	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	88.11	5.55	8.14	1.48	1.48	0.00	1.11	0.00	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	53.86	8.89	4.94	0.74	0.99	0.49	0.25	0.49	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	29.01	5.36	3.71	0.00	0.27	0.14	0.27	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	76.87	7.40	5.79	0.64	0.32	0.32	0.32	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	73.04	12.17	4.56	0.61	1.52	0.30	0.30	0.91	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	55.15	7.14	5.32	0.84	0.56	0.70	0.70	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	58.67	8.18	4.62	1.07	0.36	1.42	0.36	0.00	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.81	6.30	4.36	0.00	0.48	0.00	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.10	3.58	2.33	0.47	0.16	0.16	0.47	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	57.65	4.66	3.58	0.72	0.00	0.72	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	46.39	7.84	8.49	0.65	0.33	0.33	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	21.89	3.77	3.30	0.24	0.00	0.47	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	67.07	7.55	5.94	0.62	0.99	0.74	0.87	0.50	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	31.50	4.35	4.87	1.02	0.51	0.51	0.26	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	35.21	3.28	5.37	0.00	0.30	0.90	0.30	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	2.27	0.00	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	4.60	3.84	0.00	0.00	0.00	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.84	2.97	3.71	0.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	9.31	1.27	2.54	0.00	0.42	0.42	0.00	0.42	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	2.11	1.41	0.00	0.00	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	7.47	0.93	0.93	0.00	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	1.55	1.55	0.00	0.00	0.52	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	1.19	1.19	0.00	0.00	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.12	1.81	2.04	0.00	0.23	1.36	0.45	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	12.80	2.91	4.36	0.29	0.58	0.00	0.00	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	2.70	1.80	0.00	0.00	0.00	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	12.19	1.90	3.66	0.27	0.54	0.54	0.14	0.14	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.16	2.57	4.11	0.00	0.00	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	11.64	3.18	3.18	0.71	0.35	0.35	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	5.33	2.00	0.67	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	2.55	4.58	0.00	0.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.41	3.47	2.13	0.27	1.60	0.27	0.00	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	14.74	4.35	1.89	0.76	0.19	0.19	0.38	0.00	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.11	3.68	3.68	0.00	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	17.12	2.45	4.08	0.00	0.00	0.00	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.08	2.29	1.87	0.00	0.83	0.62	0.42	0.21	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.66	2.80	4.20	0.28	0.84	0.56	0.00	0.28	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	10.30	3.09	1.03	1.03	0.00	1.03	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.93	3.48	4.35	0.29	0.58	0.58	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.94	2.69	4.48	0.30	0.60	0.30	0.60	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	3.32	1.66	0.55	0.00	0.55	0.00	0.55	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	13.43	2.12	3.53	0.00	0.35	0.71	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	3.69	5.53	0.00	0.74	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	4.61	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.66	1.92	3.84	0.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	10.76	1.13	6.79	0.57	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	2.46	1.64	1.64	0.00	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.59	1.81	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.80	2.15	3.59	0.00	1.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	2.24	7.47	0.75	0.75	0.00	1.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	11.15	2.23	2.60	0.37	0.37	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.51	1.72	2.15	0.00	0.43	0.43	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.13	1.71	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	13.66	2.00	2.67	0.00	0.33	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.67	0.60	2.41	0.00	0.60	0.60	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	2.13	2.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.69	1.72	2.06	0.00	0.00	1.03	0.69	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	0.54	1.61	0.00	0.00	1.07	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	13.47	4.04	4.04	0.00	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.04	5.19	1.85	0.00	0.00	0.74	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	2.33	1.16	1.16	0.00	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	2.12	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.40	2.40	3.60	0.00	0.00	0.00	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	0.73	0.73	0.00	0.00	1.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.20	0.77	3.83	0.77	0.77	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	3.95	2.47	0.00	0.49	0.99	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	15.05	3.76	0.94	0.00	0.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.07	3.52	1.51	0.00	0.00	1.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.11	2.25	4.51	0.45	0.45	1.35	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	10.33	0.00	3.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.13	1.78	2.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	9.78	3.52	3.52	0.39	0.00	0.39	1.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	3.96	1.32	0.66	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.09	3.11	5.19	1.04	1.04	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	11.38	2.19	2.19	0.00	0.00	0.88	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	3.35	1.12	0.00	0.00	0.00	0.56	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	5.30	3.97	0.44	0.00	1.77	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.59	3.86	4.63	0.39	0.39	0.00	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.72	3.04	4.05	0.00	1.52	1.01	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	1.92	1.92	0.48	0.48	0.96	0.48	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.72	1.99	3.58	0.00	0.40	0.00	0.00	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.23	3.65	3.65	0.61	0.00	0.00	0.61	0.61	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	3.46	4.15	0.69	0.00	0.69	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	1.14	3.80	0.00	0.38	1.52	0.00	0.00	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.98	3.10	1.03	0.00	0.52	0.00	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.30	1.81	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	13.31	4.75	2.85	0.63	0.00	0.00	0.00	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	14.93	2.13	6.40	0.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.62	4.60	3.45	0.57	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	3.09	3.09	0.00	0.00	0.51	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.90	3.54	2.12	0.71	1.41	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	16.46	3.40	3.97	0.57	0.57	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	11.23	2.50	3.74	0.42	0.83	0.42	0.42	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	2.35	1.57	0.00	0.00	0.00	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.36	1.67	3.76	0.42	0.00	0.84	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9.76	1.86	2.79	0.00	0.00	0.46	0.46	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	4.01	4.68	0.67	0.67	0.00	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	7.48	4.81	0.00	0.00	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.74	4.04	4.04	0.81	0.40	0.40	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	2.75	2.75	0.00	0.00	0.92	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	0.89	7.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	13.68	3.42	3.99	0.57	0.57	1.71	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	10.74	2.30	3.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.25	4.38	2.74	0.00	0.00	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	11.58	2.67	1.78	0.00	0.45	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	15.60	2.60	3.64	0.00	0.26	0.52	0.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.24	1.99	5.97	0.00	0.00	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	8.31	0.00	0.00	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	107.12	5.01	5.70	0.46	1.60	0.23	0.68	0.23	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	158.18	6.24	6.79	1.65	2.94	1.10	2.02	0.55	2.02	0.37
Macrophage - monocyte derived, donor3	11389-118C3	119.94	7.73	4.06	0.79	1.97	1.31	1.31	0.52	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	92.93	6.37	5.84	1.06	2.12	0.00	1.59	1.06	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	147.36	7.76	6.65	0.95	2.54	1.11	2.85	0.48	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	135.93	5.70	6.12	1.25	3.61	1.53	2.50	0.56	1.25	0.28
Mammary Epithelial Cell, donor1	11273-116H4	108.71	11.06	13.55	2.99	2.29	1.49	2.59	1.69	1.00	0.20
Mammary Epithelial Cell, donor2	11350-117G9	101.34	8.69	8.40	1.16	1.45	1.45	0.29	0.87	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	31.43	2.24	3.49	0.50	0.00	0.75	0.50	0.50	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	338.97	10.17	10.17	0.00	7.46	0.00	7.46	0.68	4.75	0.68
Mast cell, donor1	11563-120D6	117.55	8.98	8.11	1.41	3.68	1.30	2.38	0.54	0.65	0.22
Mast cell, donor2	11565-120D8	121.54	11.29	11.00	1.19	6.24	2.08	2.38	0.59	1.78	0.30
Mast cell, donor3	11566-120D9	152.18	14.86	17.11	5.63	7.65	1.58	5.18	1.58	2.03	0.23
Mast cell, donor4	11567-120E1	124.81	8.51	12.94	2.66	7.27	1.42	3.01	1.24	1.42	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	173.55	6.54	9.20	0.89	6.21	2.22	4.44	0.89	2.44	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	181.53	4.09	6.42	0.58	2.92	0.58	3.50	0.00	2.92	0.00
Mast cell, expanded, donor5	11939-126A4	121.26	5.16	4.82	1.03	4.70	1.26	1.84	0.80	1.03	0.23
Mast cell, expanded, donor8	11941-126A6	124.19	4.85	12.39	1.00	4.35	1.84	2.85	0.33	0.67	0.84
Melanocyte - dark, donor1	11502-119F8	100.09	6.77	3.98	0.50	2.49	0.30	0.90	1.29	0.50	0.10
Melanocyte - dark, donor2	11582-120F7	78.56	8.31	5.19	1.04	0.35	0.00	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	59.11	7.97	7.17	1.74	1.81	0.65	0.94	0.29	0.14	0.43
Melanocyte - light, donor1	11274-116H5	20.45	5.17	7.99	0.94	1.41	0.24	0.47	0.24	0.24	0.24
Melanocyte - light, donor2	11351-117H1	18.43	2.73	6.14	2.05	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	18.21	6.94	4.34	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	33.84	9.37	8.64	0.94	1.15	1.25	0.42	0.42	0.21	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	47.06	7.26	7.53	0.27	0.27	0.54	0.27	1.08	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	47.95	9.64	9.64	1.34	1.61	1.61	1.07	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	45.90	14.64	11.17	0.99	0.37	0.50	0.50	0.62	0.25	0.25
Meningeal Cells, donor2	11573-120E7	45.78	14.08	12.32	0.44	0.88	0.44	0.00	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	69.77	14.18	8.72	1.79	1.87	1.06	0.90	0.90	0.41	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	68.15	9.41	10.27	1.71	0.86	0.86	0.29	0.29	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	84.93	5.53	5.43	0.81	2.01	1.31	1.21	0.30	0.70	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	6.57	5.26	0.00	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	6.54	2.62	1.31	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	69.61	11.48	0.72	1.44	0.72	0.00	0.72	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	62.26	7.20	4.45	1.91	1.69	0.42	0.64	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	56.30	11.06	6.03	0.50	1.51	1.51	1.01	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.08	8.35	6.15	1.10	0.22	0.66	0.22	0.44	0.44	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	26.30	12.42	7.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	28.24	9.21	5.52	0.20	0.00	1.43	0.41	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	92.11	8.17	8.03	0.97	0.97	0.00	0.83	0.42	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	24.53	8.92	3.72	0.74	0.37	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	86.58	11.18	7.63	1.18	1.71	1.18	1.05	1.18	0.39	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	30.56	4.75	2.97	0.00	0.30	0.59	0.59	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	2.34	11.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	32.02	3.84	7.68	1.92	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	85.78	8.51	6.03	0.71	1.42	0.35	0.71	0.71	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	78.18	8.76	6.57	0.63	1.25	0.31	0.94	0.63	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	2.18	7.26	0.73	0.73	0.73	0.00	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	229.91	57.28	15.38	3.98	4.51	1.59	2.39	3.18	0.53	1.59
Mesothelial Cells, donor2	12156-128G5	132.62	19.52	8.51	4.00	3.00	1.50	3.00	0.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	119.24	33.17	14.89	2.10	2.17	1.81	0.87	0.43	0.65	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	97.22	5.40	5.40	0.00	0.00	0.00	0.00	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	147.52	9.11	7.88	0.49	2.22	0.49	1.97	0.00	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	179.03	10.31	9.72	1.18	2.36	1.47	1.47	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	76.06	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	134.83	6.20	7.13	0.00	2.17	0.31	1.55	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	142.51	4.77	6.02	0.83	1.66	0.83	1.45	0.62	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	2.32	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	146.15	10.01	5.76	1.00	2.00	1.25	1.50	0.25	1.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	157.33	8.38	8.84	0.93	0.93	0.47	0.93	0.47	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	19.47	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	125.38	7.32	6.50	0.41	2.24	0.41	1.63	0.41	0.61	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	140.96	6.73	5.54	0.79	2.38	1.58	1.58	1.19	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	0.00	25.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	94.69	0.88	2.65	0.88	0.88	0.88	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	138.68	4.18	6.08	0.00	0.76	1.14	1.14	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	69.74	6.58	7.90	1.32	1.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	102.08	5.94	4.67	0.42	1.06	0.85	2.33	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	95.77	6.45	11.05	0.00	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	102.23	8.35	6.26	0.89	1.49	0.30	0.89	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	70.42	15.09	10.06	0.00	0.00	5.03	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	112.15	8.53	6.77	1.00	2.51	0.50	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	136.90	7.84	7.13	0.71	0.24	0.00	0.00	0.24	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	96.20	6.63	11.61	0.55	2.21	0.55	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	110.98	10.59	4.37	0.46	1.61	0.92	1.38	0.69	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	156.91	10.94	3.37	1.05	1.26	0.84	1.05	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	131.47	12.23	8.15	1.02	1.83	1.02	0.41	0.20	1.02	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	113.28	8.80	6.01	0.86	2.15	1.07	0.86	0.64	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	150.49	12.23	6.67	1.33	1.11	1.56	0.67	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	30.96	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	122.21	13.14	8.98	1.31	1.10	2.19	0.88	0.22	1.31	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	130.29	9.63	7.10	0.00	1.52	1.01	0.51	1.52	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	97.76	19.88	19.88	1.66	0.00	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	155.74	15.22	9.51	0.82	1.09	1.09	0.54	1.09	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	174.98	7.35	11.47	0.88	2.35	0.59	0.88	1.18	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	95.95	14.17	10.90	0.00	1.09	2.18	1.09	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	129.75	12.01	6.73	0.48	0.96	0.96	1.44	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	197.71	9.21	6.00	2.00	0.80	0.80	0.40	0.00	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	106.95	26.05	12.34	1.37	1.37	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	151.67	14.52	4.00	1.00	2.00	1.00	1.00	0.50	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	101.93	28.54	10.19	0.00	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	175.17	13.14	10.95	1.31	3.07	1.31	0.00	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	147.89	13.24	7.73	0.00	0.00	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	133.20	14.73	14.09	1.28	0.00	2.56	0.00	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	198.34	15.62	9.17	1.49	2.23	1.49	2.73	0.74	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	148.92	13.92	6.96	2.78	0.00	0.70	0.70	0.70	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	125.96	35.36	11.05	2.21	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	148.03	9.57	6.15	1.03	2.74	1.37	1.37	1.71	1.37	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	178.11	7.88	10.07	0.00	0.88	0.88	1.31	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	112.57	19.53	20.60	0.71	0.71	1.42	0.71	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	184.32	12.34	9.26	1.12	2.81	0.28	1.68	0.56	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	211.97	10.39	7.90	1.66	0.83	2.49	0.83	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	144.52	20.98	15.73	1.17	0.58	2.33	0.58	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	168.33	12.97	8.14	1.81	0.30	1.21	0.60	1.81	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	234.57	5.43	5.01	3.76	3.34	0.42	0.42	1.67	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	115.50	7.22	14.44	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	161.62	18.47	8.31	1.85	3.69	1.85	0.00	2.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	252.12	10.24	12.52	1.71	1.14	2.85	0.57	3.98	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	156.97	19.21	11.88	1.66	0.69	1.66	0.28	0.41	0.55	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	156.01	9.59	8.03	1.81	0.78	1.55	0.78	0.78	0.52	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	220.92	12.01	14.16	0.86	2.57	0.86	0.00	1.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	103.54	21.60	15.24	1.27	0.64	2.54	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	140.92	14.41	11.74	1.60	0.53	0.53	0.53	1.87	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	202.35	15.27	7.78	1.80	2.10	1.80	0.90	0.60	1.20	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	107.21	15.68	11.30	1.27	0.99	2.40	0.57	0.57	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	151.93	11.78	4.78	0.96	2.55	1.27	0.64	1.27	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	228.43	10.39	11.28	2.43	1.55	0.22	1.11	2.65	1.11	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	131.96	17.06	12.89	0.76	1.52	4.17	0.38	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	157.96	12.78	8.52	1.14	1.14	0.85	0.28	0.85	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	206.97	8.85	6.64	0.98	1.97	1.97	1.23	0.74	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	82.76	19.55	9.12	0.00	3.91	1.96	0.65	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	142.31	14.41	8.23	1.18	1.76	1.18	0.29	1.18	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	196.93	12.97	8.65	0.86	2.88	1.73	1.73	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	121.99	8.66	5.77	0.82	0.82	1.24	0.41	0.82	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	123.58	13.40	5.96	0.60	0.89	0.89	1.19	0.89	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	3.77	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	90.89	8.91	8.91	1.78	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	91.67	6.24	6.24	0.66	1.97	0.66	0.66	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	84.16	3.16	1.05	0.00	1.05	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	91.73	2.37	5.73	0.40	1.98	0.99	0.99	0.00	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	139.70	7.45	5.59	0.93	0.00	0.93	0.93	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	85.25	9.01	8.26	1.13	1.13	0.75	1.50	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	107.34	6.92	4.26	0.53	1.33	1.07	1.60	0.80	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	72.50	3.05	3.28	0.34	2.49	0.45	2.04	0.11	0.68	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	51.57	6.63	3.68	0.00	0.00	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	73.28	4.76	4.40	0.00	1.83	0.37	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	57.56	1.56	4.67	0.00	4.67	1.56	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	102.08	4.28	2.67	0.53	4.28	0.53	2.14	0.00	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	7.73	19.32	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	74.74	11.11	10.10	1.01	2.02	0.00	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	104.14	9.28	8.01	0.00	3.79	1.26	1.69	0.42	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	84.44	6.81	0.00	0.00	5.45	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	110.63	6.36	3.18	0.64	4.45	0.00	3.18	1.27	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	121.48	0.00	2.43	1.62	6.48	0.81	1.62	0.00	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	96.67	4.53	6.04	0.00	4.53	0.00	0.00	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	108.49	0.00	0.00	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	215.32	6.52	0.00	6.52	3.26	0.00	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	175.84	9.50	0.00	0.00	0.00	0.00	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	150.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	105.56	9.91	7.54	1.51	1.94	0.65	1.51	0.65	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	68.98	15.68	7.84	0.00	0.52	1.05	2.09	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	52.73	28.70	26.70	0.67	0.00	2.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	50.92	27.55	32.55	0.42	0.00	1.25	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	84.61	19.01	11.60	0.38	1.52	1.90	0.76	0.76	0.19	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	148.41	19.15	19.15	0.00	4.79	3.19	0.00	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	42.84	18.36	15.64	2.04	1.36	1.36	0.00	0.00	0.68	3.40
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	251.76	18.38	11.03	3.68	1.84	0.00	0.00	3.68	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	36.41	27.20	12.56	0.84	0.42	0.42	0.42	0.00	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	61.36	24.17	14.18	1.16	0.93	1.39	0.70	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	52.69	36.21	22.43	1.62	1.08	2.16	0.27	0.00	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	89.98	23.34	10.30	1.68	0.84	0.84	0.63	0.63	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	534.47	22.27	11.13	0.00	22.27	0.00	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	59.07	21.34	24.32	2.48	0.50	0.50	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	62.25	12.72	10.29	0.81	0.81	1.08	0.00	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	50.32	20.40	14.73	2.27	0.45	0.45	0.45	0.91	0.00	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.69	36.91	20.25	1.96	0.33	2.29	0.00	0.33	0.33	0.98
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	100.42	21.51	9.66	2.00	1.28	0.73	0.36	1.09	0.18	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	54.63	16.97	19.63	2.12	1.06	3.71	0.00	0.53	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	45.62	37.82	21.61	3.00	0.00	2.40	0.00	0.00	0.00	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	104.03	10.17	4.59	1.31	1.97	0.66	0.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	33.83	23.26	19.19	1.30	0.16	1.79	0.16	0.16	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	110.94	20.11	12.88	1.06	0.71	1.59	0.53	0.53	0.18	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	62.59	21.10	17.58	0.70	1.41	2.11	0.70	0.00	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	50.11	20.23	22.07	1.38	0.00	2.76	0.00	0.46	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	53.02	19.28	21.21	0.96	0.32	1.61	0.00	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	88.29	12.42	7.24	1.03	1.38	0.34	0.69	0.00	0.69	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	381.80	10.11	17.70	0.00	5.06	2.53	2.53	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	99.81	21.16	12.25	2.01	0.67	1.34	0.00	0.45	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	55.46	23.71	16.09	2.12	0.00	1.69	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	66.22	12.34	12.34	0.71	0.24	0.24	0.24	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	71.68	22.75	22.32	2.15	1.29	0.86	0.43	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	388.19	18.06	9.03	0.00	18.06	0.00	36.11	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	64.98	29.99	25.66	1.00	1.00	2.33	0.33	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	64.02	18.49	14.43	1.35	0.45	2.71	0.45	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	54.36	18.25	12.30	1.59	0.79	0.79	0.40	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	81.72	28.79	26.00	1.86	0.93	0.93	1.86	0.93	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	87.03	14.76	10.22	0.76	1.14	0.76	0.76	0.38	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	53.45	23.79	19.88	1.63	0.65	1.96	0.33	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	40.09	33.99	36.17	0.44	0.44	2.18	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	100.86	19.90	14.02	1.36	1.81	2.26	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	22.93	12.35	1.76	0.00	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	69.81	28.59	23.27	1.33	0.00	1.99	0.00	1.99	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	64.98	23.81	28.77	0.50	0.99	1.98	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	42.49	23.74	17.23	1.91	0.38	1.91	0.77	0.00	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	53.53	15.12	12.40	0.60	0.30	0.91	0.91	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	87.97	14.59	9.95	0.88	0.88	1.11	0.00	0.66	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	54.89	16.26	18.97	2.71	0.00	0.68	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	429.20	20.44	0.00	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	77.43	29.26	21.34	1.83	1.83	1.83	0.61	0.61	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	49.73	14.48	26.44	0.94	0.31	1.57	0.00	0.31	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	35.41	24.51	19.67	0.00	0.30	1.21	0.30	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	53.80	15.03	11.08	0.00	0.00	0.79	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	148.51	11.34	12.47	1.13	0.00	1.13	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	414.75	5.06	15.17	5.06	10.12	0.00	0.00	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	116.28	7.45	5.34	1.61	2.98	0.50	2.24	0.99	1.12	0.12
Myoblast, donor2	11322-117D8	102.41	11.32	7.67	1.15	0.58	2.30	1.15	0.00	0.19	0.38
Myoblast, donor3	11398-118D3	110.82	8.58	8.07	2.69	1.51	0.50	2.19	2.19	0.67	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	31.81	4.96	6.13	0.00	1.46	0.29	1.17	0.00	0.73	0.00
Natural Killer Cells, donor1	11230-116C6	112.55	18.14	20.91	1.54	2.46	0.92	2.46	0.31	2.15	0.92
Natural Killer Cells, donor2	11311-117C6	85.64	21.71	29.55	0.30	4.52	1.51	0.90	0.00	2.41	0.00
Natural Killer Cells, donor3	11387-118C1	95.34	19.88	24.11	1.66	2.39	1.84	2.76	0.00	1.29	0.18
Neural stem cells, donor1	11275-116H6	76.94	27.58	19.60	3.27	2.18	3.27	0.73	2.18	1.45	1.81
Neural stem cells, donor2	11352-117H2	48.14	25.03	23.11	1.93	1.93	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	21.62	13.65	9.10	0.00	1.14	4.55	0.00	0.00	0.00	1.14
Neurons, donor2	11574-120E8	29.50	13.21	17.83	0.88	0.44	3.96	0.66	0.44	0.22	0.00
Neurons, donor3	11655-122E8	25.49	16.44	15.62	0.00	0.82	0.00	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	351.71	25.98	22.27	0.00	3.71	2.78	12.06	0.00	1.86	0.00
Neutrophils, donor2	11314-117C9	217.42	17.39	20.29	0.00	2.90	2.90	11.60	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	750.73	41.54	44.59	3.67	15.88	3.05	8.55	1.22	3.05	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	71.60	11.16	10.21	1.54	0.71	0.00	0.59	0.83	0.47	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	50.47	8.47	7.16	0.33	0.33	0.33	0.33	0.65	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	57.76	9.43	11.23	1.20	1.40	0.20	1.00	0.40	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	69.51	14.04	15.69	0.69	1.10	2.34	1.24	0.69	0.28	0.55
Olfactory epithelial cells, donor2	11934-125I8	87.57	13.17	17.37	1.30	1.45	2.32	2.46	0.72	0.58	0.29
Olfactory epithelial cells, donor3	11935-125I9	72.08	10.33	12.49	1.48	1.02	1.82	0.79	0.57	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	87.75	17.14	14.80	1.17	1.17	2.34	0.68	1.07	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	98.70	9.63	7.22	1.20	4.21	1.81	0.00	0.00	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	58.49	3.83	4.04	1.06	2.13	0.00	0.64	0.21	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	20.58	3.43	8.00	0.00	1.14	2.29	1.14	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	42.21	4.34	11.79	2.48	0.00	0.62	0.62	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	36.74	5.08	5.86	0.20	0.20	0.98	0.39	0.78	0.00	0.00
Osteoblast, donor2	11354-117H4	78.66	8.43	7.73	1.40	2.11	0.00	2.81	1.40	1.40	0.00
Osteoblast, donor3	11426-118G4	70.38	10.66	6.04	0.89	2.31	0.36	0.89	0.53	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	73.87	4.89	6.15	1.10	1.52	0.67	1.43	1.01	0.67	0.34
Pericytes, donor1	11491-119E6	13.91	5.23	5.45	0.89	0.00	0.11	0.11	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	17.20	10.19	7.70	0.23	0.23	0.00	0.23	0.91	0.23	0.45
Pericytes, donor3	11652-122E5	33.98	9.16	9.16	0.81	0.61	1.02	0.41	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	60.81	11.19	8.93	1.02	1.13	1.02	0.57	1.24	0.23	0.11
Perineurial Cells, donor2	11579-120F4	112.71	13.62	9.11	1.47	1.93	1.01	1.93	1.20	0.74	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	104.23	15.62	14.34	1.59	2.87	1.91	4.14	0.00	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	71.01	13.96	16.16	0.98	1.22	1.22	1.47	0.24	1.71	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	70.79	12.04	17.47	1.16	2.33	1.68	0.91	0.26	0.65	0.00
Placental Epithelial Cells, donor1	11278-116H9	18.18	3.35	4.78	0.24	0.48	0.24	0.72	0.00	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	34.38	3.33	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	19.24	4.12	5.10	0.20	0.98	0.98	0.20	0.00	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	71.20	7.91	7.91	0.95	4.11	1.27	0.63	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	96.98	7.88	5.25	2.06	3.00	0.38	1.50	0.38	1.31	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	66.18	7.70	6.40	1.04	1.31	0.52	1.96	1.44	0.91	0.39
Preadipocyte - breast, donor2	11328-117E5	72.27	9.46	9.91	0.90	1.58	0.90	0.90	0.45	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	129.36	13.64	6.93	3.84	2.24	0.96	1.39	0.96	1.39	0.64
Preadipocyte - omental, donor2	11329-117E6	98.64	11.35	6.98	1.31	1.75	0.00	1.31	1.75	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	127.49	14.32	7.31	2.58	2.86	0.72	1.43	1.15	0.43	0.57
Preadipocyte - perirenal, donor1	11469-119C2	55.12	6.89	3.94	0.98	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	62.04	3.99	3.07	1.23	0.31	0.92	0.31	0.00	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	89.78	8.85	9.03	1.42	1.77	0.89	0.00	1.42	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	92.98	8.85	5.96	1.19	1.87	0.51	1.19	0.34	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	119.41	12.95	7.64	1.30	1.58	0.09	0.84	0.93	0.93	0.56
Preadipocyte - visceral, donor2	11357-117H7	90.20	5.98	10.12	1.38	5.52	0.46	0.92	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	87.04	11.70	8.67	1.36	1.57	0.10	0.84	0.84	0.42	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.63	6.49	3.17	1.51	1.21	0.00	0.75	0.15	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	59.04	7.99	7.18	1.08	0.54	1.35	0.27	0.27	0.68	0.68
Prostate Epithelial Cells, donor3	11404-118D9	42.01	8.21	12.74	2.08	0.86	1.53	0.43	0.98	0.24	0.31
Prostate Stromal Cells, donor1	11254-116F3	82.24	11.85	7.63	1.71	2.39	1.14	1.14	1.03	0.68	0.57
Prostate Stromal Cells, donor2	11332-117E9	64.01	15.60	8.79	1.08	1.61	0.72	0.90	0.36	0.18	0.54
Prostate Stromal Cells, donor3	11405-118E1	61.21	10.74	8.97	1.56	1.77	0.63	0.63	0.63	0.52	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	20.80	8.03	6.57	0.73	0.00	1.09	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	57.67	7.28	9.29	1.18	1.18	0.76	0.55	0.49	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	17.75	6.09	10.14	0.00	0.00	1.01	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	19.21	7.82	4.27	0.71	0.00	0.00	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	69.24	6.88	10.27	1.16	1.06	1.38	0.74	0.64	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.77	8.17	8.17	0.68	0.00	0.00	0.00	1.36	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	50.00	9.84	9.43	0.27	0.54	0.54	0.27	0.40	0.13	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	93.24	13.99	10.88	0.89	1.55	1.33	1.11	0.67	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	2.00	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	23.55	5.72	8.58	0.44	0.22	1.54	0.00	0.22	0.00	0.44
Renal Mesangial Cells, donor2	11598-120H5	24.45	9.40	11.29	0.63	0.00	1.25	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	14.15	5.55	7.49	0.00	0.00	0.83	0.00	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	33.82	8.86	12.35	0.27	0.54	0.54	0.54	0.27	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.66	8.43	7.17	1.27	0.00	0.42	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	25.07	11.19	9.45	0.39	0.39	1.35	0.19	0.77	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	29.82	6.48	9.85	0.26	0.78	1.56	0.52	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	12.22	5.12	7.39	0.28	0.28	1.14	0.57	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	8.23	4.12	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.59	6.52	9.79	1.25	0.50	0.75	0.00	0.25	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	90.87	8.95	9.22	0.80	4.01	1.60	2.94	0.80	1.47	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	116.14	38.42	20.55	6.25	2.68	2.68	0.89	1.79	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	145.30	33.57	16.51	3.85	2.20	2.20	2.20	0.55	2.20	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	153.13	30.74	21.46	6.96	5.80	2.32	1.74	1.16	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	121.18	40.83	35.50	2.60	2.47	1.82	2.08	0.91	0.26	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	90.77	42.60	31.78	3.28	1.39	2.88	1.39	0.99	0.30	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	114.10	33.35	24.43	1.78	2.34	3.79	2.23	1.67	0.45	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	138.18	43.42	24.44	3.85	2.98	1.74	2.11	1.36	0.99	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	94.98	40.09	31.58	2.33	2.33	3.73	0.58	1.17	0.23	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	115.57	42.76	31.90	2.08	2.08	1.62	2.54	0.46	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	101.59	43.95	30.94	3.15	1.78	2.33	0.82	1.23	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	87.59	36.31	28.29	2.57	2.42	3.33	1.21	0.76	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	117.19	38.35	28.85	2.51	2.15	3.58	0.90	1.08	0.54	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	94.97	38.59	23.96	1.58	1.72	1.15	1.15	1.15	0.86	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	88.75	30.37	22.21	2.47	1.93	3.65	1.40	1.18	0.64	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	99.57	44.25	30.31	2.43	2.21	3.76	1.11	0.89	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	99.60	38.62	28.29	3.06	1.72	1.72	1.34	0.57	0.76	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	103.04	42.95	32.33	2.33	1.40	2.33	1.12	1.02	0.19	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	124.96	35.14	28.75	3.38	1.88	3.19	1.32	1.32	0.94	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	106.70	46.31	31.05	2.79	1.86	2.65	1.46	0.93	0.66	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.85	40.88	27.45	2.24	1.65	3.02	0.78	0.97	0.49	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	102.54	34.56	24.82	1.91	1.34	2.10	2.67	1.15	1.15	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	104.98	43.46	31.18	2.35	2.03	2.78	1.28	0.75	0.43	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	89.70	33.36	23.27	1.96	2.24	5.05	1.68	0.84	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	91.60	37.08	23.93	2.05	1.20	3.25	1.20	0.51	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	108.12	40.30	31.73	1.46	1.28	2.19	1.46	0.73	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.04	34.21	28.21	2.21	1.84	3.43	0.74	0.86	1.10	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	105.84	32.24	24.85	2.96	1.21	3.49	1.75	1.34	0.27	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	114.63	33.26	23.35	3.54	3.54	1.89	0.47	0.47	0.00	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	88.10	40.67	28.57	4.56	2.18	3.17	1.19	0.60	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	102.89	36.01	26.19	1.64	2.10	4.44	3.04	1.40	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	91.24	29.44	30.90	1.45	3.32	2.07	1.45	0.41	1.04	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	97.11	37.83	27.43	2.65	3.54	1.33	2.88	1.11	0.88	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	100.26	43.24	29.24	2.72	1.25	4.39	1.88	0.84	0.63	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	111.57	40.64	31.36	2.69	1.21	1.88	1.62	0.40	0.54	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	104.22	49.22	37.98	3.92	1.70	5.28	1.02	1.19	0.85	1.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	119.15	44.73	37.98	2.31	1.93	5.98	2.31	1.16	1.35	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	121.90	37.65	24.93	2.92	2.92	1.72	1.55	1.20	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	114.67	48.42	39.78	3.29	1.92	4.80	2.61	0.96	0.69	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	136.59	39.40	25.77	2.13	3.61	4.76	2.63	0.99	1.15	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	111.29	38.35	27.61	2.39	1.19	2.73	1.53	0.85	0.34	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	105.94	43.06	27.67	2.81	3.11	2.66	1.63	0.30	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	108.75	38.65	28.52	3.47	2.40	4.00	2.40	0.80	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	86.28	67.20	40.51	3.32	1.52	1.38	0.97	1.11	0.28	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	98.34	36.67	25.48	1.67	2.62	3.81	1.19	1.19	0.24	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	122.54	58.45	34.26	2.62	2.22	5.64	0.81	1.81	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	93.89	38.99	26.09	4.52	2.17	1.51	1.79	0.66	0.38	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	113.19	53.45	35.29	5.94	3.14	3.84	1.40	1.05	1.05	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	109.70	47.15	34.15	3.63	3.93	4.23	1.21	1.51	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	111.98	37.21	25.70	4.53	2.20	1.35	1.59	0.49	0.49	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	209.16	63.46	43.08	6.26	5.39	5.53	5.68	1.75	3.64	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	110.73	38.33	21.90	4.26	4.26	2.43	3.65	1.22	1.22	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	108.50	37.67	24.71	3.01	4.22	2.41	2.11	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	115.36	60.62	34.83	11.08	3.85	2.94	1.81	0.23	0.00	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	115.32	63.20	38.64	3.89	2.10	5.99	0.90	0.90	0.60	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	110.52	34.36	28.10	7.32	3.07	1.30	1.65	0.35	0.59	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	112.91	42.90	25.40	4.27	3.20	1.92	1.71	0.43	0.85	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	115.99	40.27	18.63	3.61	1.80	1.80	0.00	0.00	0.60	1.20
Schwann Cells, donor1	11498-119F4	23.70	11.66	9.78	0.56	0.00	1.13	0.19	0.75	0.00	0.00
Schwann Cells, donor2	11578-120F3	27.22	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	53.67	8.54	6.57	0.44	0.88	1.10	0.88	0.88	0.00	0.00
Sebocyte, donor1	11220-116B5	52.04	6.03	5.48	0.55	0.55	0.55	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	30.33	6.89	5.51	0.00	0.46	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	27.83	3.92	6.80	0.21	0.62	0.82	0.00	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	132.53	24.85	11.60	3.31	1.66	0.00	0.00	1.66	3.31	3.31
Sertoli Cells, donor2	11333-117F1	81.91	19.77	16.95	5.65	8.47	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	45.66	12.76	9.94	1.14	1.14	0.09	0.35	0.62	0.18	0.26
Skeletal Muscle Cells, donor2	11358-117H8	13.01	5.78	5.06	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.93	5.02	5.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	65.82	16.34	8.33	1.26	0.94	0.16	0.47	1.26	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	63.47	14.72	6.99	1.64	0.74	0.30	0.15	0.74	0.00	0.15
Skeletal Muscle Cells, donor6	11459-119B1	76.18	17.08	10.47	1.23	0.77	0.31	0.46	0.31	0.15	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	105.85	14.36	9.20	2.39	0.76	0.50	0.88	0.76	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	73.34	12.27	8.56	0.71	0.43	0.86	0.57	0.57	0.14	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	77.58	17.66	10.02	1.88	0.79	0.69	0.60	0.69	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	73.30	9.27	10.03	0.76	1.43	0.34	1.01	0.34	0.76	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.78	9.41	5.79	0.72	0.72	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	38.25	6.88	4.95	0.69	0.83	0.28	0.28	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	88.64	34.92	40.29	2.69	0.00	0.00	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	42.24	6.63	8.36	0.72	0.43	2.02	0.14	0.14	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	83.42	10.63	9.00	2.45	0.82	1.64	0.00	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	40.38	6.10	9.48	0.52	1.04	1.43	0.52	0.26	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	91.05	9.31	7.92	2.36	1.95	1.11	1.95	0.56	0.42	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	58.51	13.08	12.94	1.55	1.83	1.97	1.41	0.56	0.42	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.98	7.82	13.11	1.90	2.33	2.33	1.27	1.27	1.90	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	66.63	14.47	17.16	2.02	1.12	2.02	0.75	1.05	0.15	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	111.40	9.26	8.64	1.23	1.54	0.00	1.85	0.62	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	66.25	11.12	9.12	1.33	0.67	0.22	1.11	0.22	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.78	5.88	6.47	0.00	2.35	0.00	0.59	1.18	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	74.25	13.70	9.72	1.10	0.44	1.33	0.66	0.66	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	48.04	7.48	4.73	0.39	1.18	0.79	0.79	0.39	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	64.12	8.50	6.95	0.77	1.55	0.77	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	10.01	4.00	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	69.20	6.79	5.46	0.93	1.33	0.93	0.53	0.67	0.40	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	79.57	12.63	5.54	1.99	2.44	0.44	1.11	0.89	0.44	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	158.89	13.06	8.45	2.43	1.79	0.64	1.66	1.28	0.26	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	63.49	10.42	7.81	1.63	1.63	0.33	0.65	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	89.19	8.27	6.20	1.48	1.77	0.89	1.77	1.18	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	94.39	13.52	7.97	0.85	0.85	0.85	1.14	0.28	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	15.94	6.18	4.07	0.65	0.00	0.49	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	88.89	26.79	14.31	2.74	1.22	0.91	1.22	2.13	0.91	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	57.08	7.58	3.54	1.77	0.76	0.51	0.76	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	43.87	6.68	6.20	1.43	0.48	0.95	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	76.39	6.64	7.23	1.18	0.74	0.59	0.88	1.18	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	72.54	10.76	5.60	0.86	1.72	0.86	0.43	0.65	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	71.06	12.39	8.29	1.89	1.47	0.94	0.63	0.42	0.31	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	53.67	8.20	5.10	0.77	0.62	0.62	0.62	0.93	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	56.05	3.23	3.23	0.00	1.08	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	59.17	6.87	6.87	0.60	0.00	0.60	0.60	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.12	2.05	3.76	0.34	0.00	0.68	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	72.95	7.70	9.19	0.47	1.41	0.94	1.10	0.39	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	107.79	10.87	10.67	3.52	4.63	1.51	0.81	1.41	0.20	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	112.18	12.74	10.01	0.91	1.59	1.82	0.46	0.46	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	3.62	5.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.74	12.98	11.13	1.32	2.12	1.06	0.79	0.53	0.53	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	74.70	5.33	8.79	1.07	1.46	0.80	0.93	0.13	0.40	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	62.86	7.64	8.26	1.63	1.50	1.88	0.63	0.25	0.25	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	89.29	8.37	4.82	3.30	0.25	0.25	0.25	1.01	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	150.62	15.38	8.74	3.62	1.81	1.06	1.06	2.26	0.15	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	45.76	6.00	2.25	0.75	1.50	0.00	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	93.04	11.63	5.17	1.29	0.00	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	44.18	2.33	5.58	0.93	0.93	1.40	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	60.59	6.56	3.53	2.52	1.01	1.01	1.01	1.51	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	84.62	13.48	10.03	2.19	1.57	0.94	0.31	0.31	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.42	4.72	3.24	0.00	0.29	0.29	0.29	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	79.81	11.75	10.25	1.42	1.58	1.08	1.33	1.00	0.42	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	100.44	14.48	10.28	1.87	0.47	2.80	0.00	0.47	0.47	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	71.38	9.35	5.32	1.15	1.01	0.43	0.29	0.72	0.14	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	57.62	6.12	7.39	0.76	1.27	1.02	1.02	1.27	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	50.77	9.40	5.26	0.19	0.00	0.19	0.38	1.32	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	84.13	8.11	11.32	1.54	0.98	1.12	1.54	0.70	0.28	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	73.48	7.62	8.38	0.34	1.68	1.84	1.17	0.59	0.42	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.62	1.43	2.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	77.07	6.85	5.87	0.73	1.22	1.22	0.98	0.24	0.49	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	117.10	11.71	10.83	1.99	2.43	0.88	2.21	1.10	1.99	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.32	0.88	4.97	2.05	1.46	0.29	0.88	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.98	5.44	8.16	0.97	1.75	0.97	0.19	0.78	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.18	6.35	5.29	1.85	1.59	0.53	2.12	0.79	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	66.95	4.09	3.35	1.12	2.23	1.12	1.12	0.74	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	69.71	3.95	5.75	2.16	1.80	0.72	0.00	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	73.81	6.53	7.95	1.70	0.85	1.70	0.28	0.28	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	77.20	7.48	5.12	0.00	1.58	0.79	1.18	0.79	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	71.11	5.59	4.83	1.02	2.03	1.02	0.25	0.76	0.25	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	68.28	10.38	11.58	2.40	1.60	0.80	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	58.52	7.11	7.52	0.84	1.67	0.00	1.25	0.00	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	67.38	8.71	8.25	0.92	1.38	0.92	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	100.99	8.25	5.72	1.51	3.03	0.50	2.19	0.84	1.18	0.34
Synoviocyte, donor2	11368-117I9	60.68	9.39	6.54	0.50	1.01	0.00	0.67	1.01	0.17	0.00
Synoviocyte, donor3	11440-118H9	69.93	10.50	7.37	1.12	1.12	0.45	0.89	0.67	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	23.94	8.58	6.79	0.00	0.00	1.07	0.36	1.07	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	35.68	3.96	5.95	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	22.23	12.50	11.11	1.16	0.23	0.93	0.23	0.23	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	46.74	5.30	6.38	0.72	1.15	0.79	0.43	0.43	0.29	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	25.51	4.64	1.93	0.77	0.39	0.77	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	29.21	4.01	6.30	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	102.73	10.21	9.96	1.11	3.44	1.11	2.71	0.25	1.11	0.12
Urethra, donor2	10319-105A4	66.54	23.38	26.98	0.00	0.00	0.00	1.80	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	18.86	4.25	4.52	0.80	0.27	0.80	0.00	1.06	0.00	0.27
Urothelial Cells, donor2	11600-120H7	27.24	3.61	2.80	0.00	0.40	0.80	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	17.88	4.13	2.98	0.00	0.00	0.23	0.23	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	100.75	4.46	7.58	0.89	1.56	1.11	0.67	0.89	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	243.80	6.23	21.35	1.78	4.45	0.89	4.45	0.00	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	261.62	8.58	10.01	2.86	4.29	0.00	2.86	0.00	7.15	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	160.86	6.85	13.01	2.05	0.68	1.37	0.68	0.68	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	140.49	9.99	13.08	0.00	2.07	1.03	2.07	0.34	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	160.36	7.55	10.46	0.58	1.74	0.00	2.91	0.58	2.91	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	235.32	8.33	16.66	0.00	3.12	0.00	6.25	2.08	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	227.61	13.77	6.42	0.00	3.67	0.00	3.67	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	123.24	2.74	15.52	0.00	3.65	0.00	3.65	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.61	10.73	6.78	0.74	0.62	0.99	0.49	0.37	0.25	0.49
Wilms' tumor cell line:HFWT	10597-108E3	14.08	21.12	10.56	0.00	0.00	0.00	0.00	2.64	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	48.88	7.54	9.78	1.68	0.56	1.12	0.84	0.84	0.28	0.00
achilles tendon, donor2	10292-104G4	103.33	24.80	8.27	2.07	0.00	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	47.68	10.20	8.16	0.76	1.53	1.02	0.51	0.00	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	23.45	8.13	6.73	0.00	0.00	0.23	1.16	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.94	9.62	15.91	0.47	0.83	1.54	0.36	0.12	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	57.96	3.54	9.52	0.27	1.09	0.54	0.27	0.54	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	59.31	9.28	12.37	0.56	1.12	1.41	0.84	0.56	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	74.23	6.77	10.15	1.06	2.96	0.42	0.85	0.42	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	91.74	9.26	7.62	0.54	2.18	1.63	0.27	1.09	1.09	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	63.89	3.97	5.73	0.88	1.76	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	59.62	4.90	8.58	0.00	3.68	0.00	1.23	0.41	1.23	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	31.84	12.04	9.32	0.39	2.33	0.00	1.55	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.85	1.84	3.68	0.00	0.74	0.00	0.18	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	81.91	15.60	15.60	0.00	0.00	0.00	0.00	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	71.11	6.27	5.34	0.70	0.93	1.86	0.46	0.70	0.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	37.28	5.70	5.95	1.04	1.29	0.52	0.52	0.26	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	37.99	5.55	5.84	1.17	1.17	0.58	0.29	0.29	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	51.59	5.58	3.25	0.93	1.39	0.93	0.00	0.00	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	51.82	4.52	9.46	0.41	0.41	0.82	2.47	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	24.25	6.45	15.35	1.23	0.31	4.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	56.75	5.12	8.11	2.56	2.99	1.28	1.28	0.43	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	56.72	3.94	5.16	0.61	2.43	0.61	0.61	0.61	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.88	4.09	6.50	0.96	1.44	1.93	1.93	1.20	1.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	33.41	2.67	3.12	0.67	0.67	0.00	0.22	0.22	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	31.69	6.34	6.00	0.00	0.67	1.33	0.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	20.44	9.29	0.00	0.00	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	88.89	16.95	6.03	1.88	0.75	1.51	0.75	0.75	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	86.79	18.75	14.83	0.87	0.87	1.31	0.44	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	93.72	15.00	20.62	0.00	0.00	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	51.34	5.18	7.77	0.47	1.65	1.88	0.94	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	159.15	14.12	11.01	2.48	1.71	0.62	1.55	1.09	0.62	0.31
adipose, donor1	10184-103D4	32.84	18.77	5.28	5.86	1.76	0.59	1.17	0.59	0.59	0.00
adipose, donor2	10185-103D5	13.38	33.25	32.44	5.68	0.41	2.43	0.41	0.00	0.00	1.22
adipose, donor3	10186-103D6	20.97	23.14	17.97	4.90	0.82	2.18	0.00	1.09	0.00	0.54
adipose, donor4	10187-103D7	30.34	12.13	12.13	4.33	0.87	0.00	0.00	1.73	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.72	4.73	11.68	1.42	0.00	2.37	0.00	2.05	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	7.28	21.83	0.00	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.70	2.53	6.00	0.40	0.67	1.07	0.53	0.80	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	53.59	6.43	10.72	0.71	2.86	1.43	0.36	0.36	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	105.26	2.78	6.49	1.16	4.17	0.93	4.87	0.93	3.01	0.00
amniotic membrane cells, donor2	12236-129G4	84.86	3.72	10.48	0.34	3.04	0.00	1.35	1.01	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	109.59	2.65	5.01	1.77	3.83	1.18	4.71	0.59	2.06	0.00
amygdala - adult, donor10196	10167-103B5	55.73	20.16	15.42	1.19	0.00	3.56	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	55.36	19.87	19.47	1.82	0.61	3.24	0.81	0.61	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	52.29	14.85	11.62	1.61	0.00	3.87	0.97	0.65	0.65	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	53.48	8.28	10.06	1.40	1.53	1.15	0.25	0.38	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.36	7.72	9.05	0.44	0.22	0.00	1.10	0.44	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.06	18.71	11.36	0.67	1.34	0.67	1.67	0.00	1.00	0.00
aorta, adult, pool1	10052-101G7	60.80	20.99	15.49	0.59	1.37	1.57	0.39	0.20	0.20	0.39
appendix, adult	10189-103D9	85.77	16.30	17.08	1.55	1.16	0.39	1.16	0.00	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	35.43	9.29	5.50	0.00	1.38	0.69	0.69	0.34	0.00	0.00
artery, adult	10190-103E1	130.43	16.30	16.30	1.36	5.43	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	87.35	31.87	14.05	1.74	1.16	0.87	0.72	1.30	0.29	0.29
b cell line:RPMI1788	10427-106D4	72.12	9.81	7.88	1.34	0.59	0.59	0.45	1.49	0.30	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	120.41	10.27	3.88	1.66	1.11	1.66	3.05	1.11	0.55	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	61.42	7.94	6.85	0.89	2.18	0.79	0.60	0.99	0.69	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	25.27	7.87	7.03	0.67	1.67	0.67	1.17	0.67	0.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.79	5.59	6.71	0.56	0.56	1.68	0.00	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	91.37	16.95	18.36	2.39	2.39	2.06	1.09	0.87	0.11	0.33
blood, adult, pool1	10053-101G8	79.73	17.72	17.72	0.00	6.64	2.21	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	70.22	3.43	5.14	3.43	1.71	0.00	0.00	1.71	1.71	0.00
bone marrow, adult	10192-103E3	138.34	12.82	10.80	4.05	4.05	0.00	2.70	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	26.65	22.55	16.40	3.08	1.03	5.13	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	33.07	16.04	15.59	2.00	0.22	2.34	0.78	0.67	0.11	0.00
brain, fetal, pool1	10085-102B4	50.76	24.04	66.78	0.00	0.00	18.70	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	30.06	3.96	12.55	0.66	0.33	0.99	0.00	0.00	0.66	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	69.03	5.49	10.86	0.75	3.74	2.00	2.50	0.25	1.12	0.00
breast, adult, donor1	10080-102A8	134.48	36.62	14.52	1.89	1.89	1.89	0.63	0.00	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.35	3.18	8.51	0.51	1.02	0.76	0.76	0.13	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	56.28	14.53	11.44	0.62	1.24	0.93	0.93	0.62	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	110.51	4.60	3.45	1.38	0.69	2.07	0.23	2.07	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	50.84	5.81	10.89	0.48	1.69	0.97	0.97	0.48	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	31.50	33.38	18.34	0.00	0.94	0.47	0.47	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	72.41	20.45	10.83	2.19	2.08	0.98	1.31	0.33	0.44	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	34.54	10.14	14.26	0.00	0.00	2.54	0.32	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	70.27	32.47	21.03	2.40	1.33	0.27	0.00	0.00	0.00	1.60
caudate nucleus - adult, donor10196	10177-103C6	88.65	25.33	31.09	3.45	1.15	3.45	0.00	2.30	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	68.27	17.90	21.92	1.00	0.67	3.68	1.00	0.84	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	47.38	9.93	9.93	1.53	1.53	3.06	0.76	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	64.09	19.41	21.24	2.20	0.37	4.03	0.00	0.37	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	75.75	40.79	40.79	0.00	0.00	2.91	0.00	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	70.03	28.61	16.44	2.56	1.49	2.56	1.49	1.49	0.21	0.43
cerebellum, adult, pool1	10083-102B2	22.08	21.39	22.08	1.03	1.03	3.10	0.34	0.69	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	103.79	29.89	17.44	2.49	0.83	2.49	1.66	1.66	0.83	0.00
cerebral meninges, adult	10188-103D8	53.71	17.15	16.64	1.51	0.25	2.27	0.25	0.76	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	110.36	16.81	11.69	0.73	1.46	0.73	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	23.44	8.05	7.91	0.43	0.43	0.58	0.43	0.29	0.43	0.29
cervical cancer cell line:ME-180	10553-107I4	31.32	5.47	8.12	0.33	0.99	1.16	1.16	0.33	0.33	0.17
cervix, adult, pool1	10013-101C4	82.63	17.43	17.01	2.41	1.57	3.04	2.10	0.42	0.21	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	107.71	21.32	10.73	2.23	2.23	0.56	1.39	0.56	0.70	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	74.46	3.92	9.14	1.31	1.31	1.31	0.00	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	79.29	19.88	16.90	5.34	1.74	1.86	0.62	1.12	1.49	1.49
choriocarcinoma cell line:SCH	10785-110H2	22.55	11.58	8.01	0.86	0.37	0.49	0.74	0.37	0.12	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	41.74	9.25	11.62	1.66	0.00	2.37	0.47	1.42	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	71.80	2.28	5.70	0.57	3.70	1.99	4.27	0.00	1.99	0.00
chorionic membrane cells, donor2	12239-129G7	85.41	9.74	9.55	1.89	4.18	0.80	2.98	1.09	0.99	0.20
chorionic membrane cells, donor3	12240-129G8	90.12	6.04	4.95	2.20	2.75	1.10	6.59	2.20	4.40	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	27.26	4.04	5.05	1.01	0.00	1.01	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.79	5.19	5.96	0.00	1.15	0.19	1.15	0.00	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	88.28	16.26	21.12	0.63	1.69	1.48	2.53	1.06	1.06	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.88	7.45	9.76	0.26	0.00	1.80	0.26	1.03	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	29.03	10.40	9.92	0.73	0.00	3.39	0.48	0.24	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.43	10.18	10.99	0.61	0.00	1.02	0.41	0.20	0.41	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	29.45	6.18	10.01	0.29	1.47	1.77	0.29	0.59	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	84.96	18.24	25.28	0.52	3.13	2.87	2.09	0.78	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	83.20	7.77	9.60	1.14	0.46	1.83	0.46	0.69	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	20.65	3.12	2.26	1.04	0.52	0.17	0.35	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	32.58	6.22	3.29	0.55	0.00	0.18	0.73	0.18	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	8.36	4.18	5.32	1.52	0.76	0.76	0.00	0.00	0.38	0.38
colon, adult, donor1	10082-102B1	59.50	11.90	19.04	0.00	1.19	4.76	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	96.12	17.27	12.69	2.59	4.35	1.41	3.64	1.06	1.53	0.35
colon, fetal, donor1	10070-101I7	116.18	30.90	33.99	3.71	2.47	6.18	3.09	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	73.34	27.50	45.84	9.17	0.00	4.58	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	40.79	8.07	2.97	0.85	1.70	0.00	0.00	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	35.17	4.08	4.83	0.30	1.06	0.30	0.30	0.30	0.30	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	37.23	3.24	3.53	0.71	0.42	0.14	0.85	0.00	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	58.93	28.53	32.51	2.43	0.66	4.98	0.44	0.66	0.22	0.11
cruciate ligament, donor2	10295-104G7	122.38	18.64	17.02	4.86	1.62	1.62	1.62	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	150.08	37.72	16.05	1.61	0.80	1.61	2.41	1.61	0.00	0.80
diencephalon, adult	10193-103E4	38.64	19.68	14.40	1.20	0.48	3.12	0.24	0.96	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	26.18	8.04	4.13	0.46	2.07	0.23	0.69	0.23	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	63.60	8.21	8.72	1.54	2.05	1.54	1.54	0.77	1.03	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	51.27	6.74	10.83	0.72	0.72	1.69	0.48	1.69	0.24	0.00
ductus deferens, adult	10196-103E7	103.16	9.47	13.46	1.50	3.49	3.49	4.49	1.00	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	72.01	20.16	37.45	2.88	1.44	2.88	0.00	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	79.45	12.51	13.24	1.47	2.94	0.74	2.94	0.74	0.00	0.74
dura mater, adult, donor1	10041-101F5	96.13	27.01	20.65	2.15	1.73	1.40	1.32	0.99	0.50	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	56.63	14.43	6.66	3.78	2.44	0.22	2.00	0.89	0.67	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	51.59	17.34	6.30	3.15	0.72	0.29	0.72	1.00	0.57	2.01
embryonic pancreas cell line:1B2C6	10604-108F1	49.95	15.42	10.48	0.62	0.00	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	41.47	6.36	9.99	0.61	0.61	0.30	0.30	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	51.87	15.75	12.97	0.62	0.62	2.47	0.31	0.00	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	48.60	18.39	17.08	1.31	1.31	0.00	1.31	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.82	19.11	12.40	1.68	0.34	0.34	0.34	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	63.07	7.25	8.70	1.27	1.45	2.54	0.91	0.91	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.43	2.41	3.70	0.48	1.45	0.00	0.16	0.64	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	50.35	8.56	13.56	1.11	0.78	0.56	0.78	0.56	0.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	53.89	6.05	10.56	0.55	1.10	1.21	0.66	0.44	0.22	0.11
epididymis, adult	10197-103E8	103.40	12.98	12.56	3.77	2.30	1.47	2.30	0.21	0.21	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.43	4.79	6.39	0.89	0.35	0.35	0.35	0.53	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.57	10.62	9.04	1.18	0.00	0.39	0.79	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	32.89	4.19	5.37	0.66	0.39	1.97	1.31	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	30.90	7.28	7.68	0.69	0.69	2.07	0.79	0.49	0.59	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.27	5.04	4.71	0.45	0.56	0.90	0.45	0.67	0.34	0.22
esophagus, adult, pool1	10015-101C6	115.31	10.19	12.21	1.27	2.55	1.70	2.12	0.53	0.64	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	19.79	9.52	9.89	2.63	0.38	2.00	0.13	0.00	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	91.75	31.39	16.90	7.24	2.41	0.00	0.00	0.00	2.41	2.41
eye - muscle lateral, donor2	10298-104H1	105.21	14.73	6.31	0.00	2.10	6.31	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	78.88	10.42	11.91	1.49	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	17.20	14.90	0.00	0.00	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	59.75	26.23	20.40	2.91	2.91	1.46	1.46	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	56.44	18.05	17.80	0.76	1.53	3.05	1.27	0.76	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	38.34	8.85	8.59	0.38	0.77	0.90	0.64	1.03	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.87	8.55	8.55	0.47	1.19	0.71	1.19	1.19	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	38.75	16.51	17.45	1.50	0.56	2.91	0.84	0.66	0.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	69.06	15.31	18.32	3.00	1.80	1.50	1.80	0.60	1.20	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.88	9.78	9.24	1.10	1.28	0.82	0.91	1.01	0.37	0.18
gall bladder, adult	10198-103E9	53.12	7.24	11.35	1.45	0.72	1.45	1.21	0.72	0.24	0.00
gamma delta positive T cells, donor1	11937-126A2	99.85	4.83	17.72	0.00	0.54	1.61	2.15	0.00	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	89.26	11.58	13.45	0.75	4.48	2.61	2.61	0.75	2.61	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	57.87	12.67	6.76	2.11	1.27	0.63	0.63	0.84	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	37.33	13.54	9.09	1.55	1.93	1.35	0.58	0.58	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	46.24	7.54	7.38	1.31	1.31	0.49	0.16	0.98	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	54.91	2.75	1.83	1.83	0.00	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.30	17.82	3.88	0.46	0.46	0.23	0.46	0.00	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	12.51	5.62	4.82	0.46	0.00	0.46	0.23	0.00	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	44.23	7.14	9.10	1.12	0.42	0.84	0.14	0.42	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	48.64	6.73	6.73	1.50	1.50	0.75	2.24	0.75	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	40.11	5.28	3.69	0.95	0.32	1.27	1.16	0.11	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	42.55	4.63	5.20	0.14	1.40	1.40	0.84	0.28	0.98	0.00
glioblastoma cell line:T98G	10485-107A8	63.58	5.08	4.53	0.99	1.55	0.44	1.43	0.77	0.55	0.11
glioma cell line:GI-1	10413-106B8	62.97	11.72	6.44	2.34	1.76	0.00	1.17	1.46	0.59	1.76
globus pallidus - adult, donor10196	10175-103C4	67.06	46.65	34.26	3.64	0.73	10.20	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	85.92	15.62	20.75	2.44	0.73	4.39	0.73	0.73	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	31.49	10.95	15.06	0.00	0.00	0.00	2.74	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	60.75	23.45	15.45	1.60	0.00	3.20	1.07	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	39.15	29.37	2.45	2.45	0.00	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	95.36	13.76	6.40	0.64	1.28	0.96	0.64	0.00	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	23.87	17.91	11.94	0.92	0.92	0.92	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	20.58	13.72	4.57	1.83	0.00	0.46	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.81	21.90	5.15	0.00	0.00	0.00	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	18.68	2.87	1.44	0.00	0.00	1.44	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	15.09	10.97	4.12	1.37	0.00	0.69	0.00	0.00	0.00	0.69
hIPS, biol_rep3	14382-156B8	37.52	6.62	11.03	3.31	1.10	1.10	0.00	2.21	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	33.91	3.74	6.32	0.00	0.29	0.29	0.57	1.15	0.29	0.00
heart - mitral valve, adult	10205-103F7	123.77	29.60	14.05	0.90	1.49	1.79	2.69	0.90	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	113.74	18.83	17.26	2.09	2.88	2.35	3.40	0.52	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	158.20	30.81	13.32	1.67	3.33	0.83	0.83	0.00	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	54.07	15.71	13.67	1.02	0.61	1.84	1.63	0.82	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	69.41	18.74	16.18	0.85	0.43	0.85	0.00	0.00	0.00	0.43
heart, adult, pool1	10016-101C7	171.33	25.30	18.63	3.91	2.30	2.07	1.61	1.38	0.69	0.46
heart, fetal, pool1	10046-101G1	161.93	50.01	37.38	2.05	2.98	4.42	2.98	1.23	1.33	0.92
hepatic mesenchymal tumor cell line:LI90	10778-110G4	132.97	16.66	12.34	0.93	2.16	1.85	0.62	1.54	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	96.32	22.59	17.84	2.38	0.00	1.19	3.57	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.71	26.63	10.28	2.43	1.10	0.99	1.10	0.99	0.55	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.50	25.73	9.71	0.61	1.82	0.85	1.58	0.97	0.36	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	54.97	23.95	9.30	1.92	1.21	0.30	0.91	0.51	0.40	0.61
hepatoma cell line:Li-7	10484-107A7	44.38	13.46	4.00	2.00	1.00	0.22	0.33	0.89	0.22	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	34.27	9.25	5.63	1.41	0.40	0.40	0.10	0.50	0.10	0.50
hippocampus - adult, donor10196	10169-103B7	44.48	16.09	27.44	2.84	0.00	2.84	0.00	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	69.19	20.00	23.47	1.63	0.61	3.06	0.82	1.43	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	24.90	5.98	1.99	1.49	0.00	0.50	0.00	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	35.25	17.62	22.21	1.76	0.70	4.58	0.00	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	26.86	13.43	9.16	2.44	1.22	0.00	0.00	0.61	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.92	18.65	12.17	1.18	0.20	1.57	0.00	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.03	14.22	14.98	2.29	0.51	1.52	0.00	0.00	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.02	21.99	34.96	5.64	0.00	1.69	0.00	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.98	28.66	27.63	11.36	0.77	0.52	0.26	0.00	0.00	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	15.56	16.70	15.18	7.21	0.76	1.52	0.38	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	21.02	15.47	18.10	3.21	0.29	0.58	0.00	0.00	0.29	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	16.80	28.22	22.62	6.03	0.22	1.29	0.43	0.43	0.22	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.10	14.18	12.51	4.59	1.67	2.09	0.42	0.00	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	28.42	12.79	10.89	0.95	0.95	0.47	0.24	0.00	0.71	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	22.66	21.86	13.82	4.34	0.16	2.25	0.96	0.32	0.16	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	39.72	12.79	13.47	2.02	0.00	0.67	0.00	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	15.18	15.65	11.11	1.41	0.31	0.78	0.00	0.00	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	13.76	18.18	9.83	0.98	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	23.56	6.98	5.24	0.00	0.87	0.00	0.87	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	18.90	35.13	27.49	7.64	0.00	2.67	0.38	0.57	0.00	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	18.75	37.07	30.09	9.16	0.87	3.05	0.44	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	16.99	18.99	12.49	5.50	0.00	2.00	0.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	11.12	22.61	25.62	5.84	0.00	2.07	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.28	20.92	30.47	5.91	0.00	2.73	0.45	0.45	0.00	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	15.35	25.69	24.12	3.13	0.31	2.19	0.94	0.31	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	20.90	24.50	13.88	5.88	0.82	2.29	0.82	0.33	0.65	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	16.84	24.39	14.81	4.64	0.58	0.58	0.58	0.00	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.73	20.33	16.74	3.89	0.30	1.49	0.30	0.30	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	19.40	16.07	13.86	2.77	0.55	1.85	0.18	0.18	0.18	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.12	21.40	15.41	0.86	0.57	1.14	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.32	13.07	10.21	2.04	0.41	0.82	0.41	0.82	0.41	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	18.31	24.29	17.60	7.04	0.70	2.11	0.00	0.70	0.00	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	20.59	29.46	23.76	8.24	0.63	2.22	0.00	0.32	0.63	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.34	19.67	17.55	4.84	0.61	1.51	0.00	0.30	0.30	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.20	21.20	18.62	4.14	0.52	3.10	0.00	0.52	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.93	23.91	18.60	3.98	0.66	1.99	0.00	1.33	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.32	13.34	10.52	2.31	0.51	0.77	0.77	0.77	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	27.61	14.06	9.97	4.35	0.26	0.77	0.77	0.26	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	32.56	24.23	15.14	6.82	0.76	3.79	0.00	0.00	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.97	17.47	10.42	4.03	1.68	0.67	0.67	0.00	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.56	18.60	13.28	2.17	0.72	0.72	0.00	0.00	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	24.07	12.03	8.02	1.78	0.45	1.34	0.45	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	18.05	20.49	12.20	1.95	0.00	1.95	0.00	0.98	0.00	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	13.75	25.06	17.73	5.20	0.00	2.44	0.00	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	26.03	13.01	16.27	6.51	3.25	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	17.54	12.91	7.28	6.29	0.99	0.33	0.00	0.33	0.33	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	15.32	20.25	15.32	3.83	0.00	2.19	0.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	14.11	16.65	17.37	3.62	0.36	0.72	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.10	18.51	11.39	6.05	0.71	0.36	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	16.71	8.35	2.39	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	24.24	20.99	17.06	4.06	0.68	1.35	0.41	0.14	0.54	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.13	16.43	13.74	2.69	0.27	0.81	0.00	0.00	0.00	0.54
immature langerhans cells, donor1	11904-125F5	95.65	10.90	10.65	0.73	4.84	0.97	4.60	0.24	3.15	0.24
immature langerhans cells, donor2	11905-125F6	34.85	7.13	15.84	0.79	4.75	0.79	1.58	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	36.91	15.33	16.94	1.51	0.47	2.56	0.57	0.47	0.09	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	24.39	9.43	10.08	1.63	0.65	2.60	0.65	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	87.21	11.71	10.71	1.60	2.80	1.40	2.10	0.20	0.70	0.10
kidney, fetal, pool1	10045-101F9	45.70	15.92	12.52	0.71	0.71	1.49	0.57	0.21	0.07	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	49.57	17.04	15.20	2.41	0.71	1.56	0.71	1.70	0.43	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.41	6.08	4.15	1.38	0.14	0.28	0.14	0.14	0.00	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	57.99	17.98	13.76	1.47	0.55	2.75	0.73	0.37	0.37	0.73
left atrium, adult, donor1	10079-102A7	99.71	26.15	17.44	3.27	2.18	1.09	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	126.41	58.15	36.91	7.08	2.02	4.05	1.52	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	34.47	11.22	13.68	0.27	0.00	1.92	0.00	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	55.68	7.54	4.31	1.80	0.72	0.72	0.36	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	84.78	7.07	4.35	2.72	1.63	0.54	1.09	1.63	0.54	0.00
leiomyoma cell line:15425	10571-108B4	84.50	5.58	5.83	2.91	1.21	1.70	0.24	0.49	0.00	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	133.34	12.70	6.35	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	19.87	12.55	2.09	1.05	1.05	2.09	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	102.47	22.43	14.64	1.18	2.13	1.53	1.77	0.59	0.24	0.12
liposarcoma cell line:KMLS-1	10782-110G8	72.01	6.25	7.03	1.25	1.25	1.87	1.09	0.78	0.47	0.47
liposarcoma cell line:SW 872	10726-110A6	50.08	11.70	7.92	0.97	0.37	0.49	1.10	0.12	0.24	0.12
liver, adult, pool1	10018-101C9	73.09	8.27	7.94	1.46	1.78	1.62	1.13	0.00	0.81	0.16
liver, fetal, pool1	10086-102B5	28.22	14.11	9.41	0.94	0.00	1.88	0.94	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	65.04	37.04	23.77	1.90	0.73	4.37	0.44	1.02	0.29	0.29
locus coeruleus, adult, donor10252	10165-103B3	62.93	21.96	18.64	1.66	0.74	1.11	0.37	0.37	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	33.57	23.14	18.62	1.97	0.28	5.36	0.56	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	87.07	17.25	11.78	5.05	2.10	1.26	0.00	1.26	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	36.95	4.84	5.54	0.97	0.97	0.42	0.69	0.14	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	39.99	1.38	9.65	0.00	0.69	0.00	2.07	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	90.56	10.41	15.42	1.71	1.85	1.71	1.19	0.53	0.79	0.13
lung, adult, pool1	10019-101D1	99.46	13.94	16.30	2.01	2.72	1.30	1.54	0.47	0.12	0.12
lung, fetal, donor1	10068-101I5	188.37	35.96	33.39	3.14	3.14	1.14	3.42	1.14	1.43	0.86
lung, right lower lobe, adult, donor1	10075-102A3	82.94	25.20	29.33	6.87	2.29	2.75	0.00	0.92	0.00	0.46
lymph node, adult, donor1	10077-102A5	108.40	20.83	23.67	0.95	2.37	0.95	1.42	0.95	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	51.73	7.67	10.08	0.22	0.88	0.88	0.22	0.22	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	47.99	12.53	6.04	0.75	2.11	0.30	1.21	0.30	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	93.44	10.19	4.25	2.55	3.40	1.70	4.25	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	243.31	32.41	15.54	4.88	1.33	0.44	1.33	0.89	1.33	0.89
mature adipocyte, donor2	12232-129F9	255.47	26.36	10.38	2.91	2.08	0.00	1.04	1.66	1.04	1.45
mature adipocyte, donor3	12233-129G1	290.17	38.64	11.85	6.16	3.08	0.24	3.56	3.08	0.47	2.61
mature adipocyte, donor4	12234-129G2	297.44	32.11	11.84	7.11	2.37	0.00	1.58	1.58	0.53	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	109.84	16.92	19.54	2.14	3.34	4.77	2.62	0.71	2.14	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	24.82	12.41	2.26	0.00	2.26	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	52.23	17.47	21.15	0.74	0.74	2.02	0.74	0.55	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	29.23	11.44	13.03	0.95	0.64	0.64	0.64	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	101.08	10.66	7.68	4.26	0.85	2.13	0.85	1.28	0.43	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	43.71	18.06	18.56	1.18	1.52	2.87	0.51	0.68	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	57.09	19.10	18.68	2.97	1.27	2.33	0.85	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	7.71	1.93	0.00	0.00	1.93	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	143.54	0.00	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	56.35	17.95	17.59	1.79	0.36	1.44	0.72	1.44	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	55.16	27.91	15.58	0.65	2.60	3.24	0.65	0.65	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	63.78	18.73	18.11	1.86	1.55	2.32	1.39	0.77	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	45.30	20.24	17.22	1.55	0.33	2.37	0.73	0.90	0.24	0.41
medulla oblongata, newborn, donor10223	10361-105F1	59.02	21.53	21.53	1.04	0.69	1.74	0.35	0.69	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	21.26	25.24	11.73	1.77	0.44	1.11	0.22	0.66	0.22	0.22
medulloblastoma cell line:ONS-76	10759-110E3	40.96	8.44	9.90	1.22	0.49	2.08	0.37	0.24	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	55.63	10.35	6.61	2.01	1.87	1.15	2.01	0.29	1.58	0.29
melanoma cell line:G-361	10465-106H6	34.20	5.70	5.97	3.26	1.09	0.27	0.00	0.54	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	60.78	7.96	3.26	0.18	0.90	1.27	0.90	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.89	30.84	12.34	0.88	0.00	0.88	0.00	0.00	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	21.00	21.00	16.07	0.26	0.78	0.78	0.52	0.00	0.26	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	110.93	7.36	5.98	1.38	2.30	0.46	1.53	0.61	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	81.07	8.18	6.18	0.55	1.27	0.18	0.73	0.55	0.55	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	91.10	4.97	5.38	0.00	2.07	0.00	0.41	0.00	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	105.78	8.01	4.78	0.84	2.67	0.28	1.12	1.12	0.14	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	116.89	8.28	7.32	0.58	1.35	0.00	0.19	0.77	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	131.18	17.35	4.86	1.39	2.08	0.00	2.08	0.69	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	99.55	8.58	4.12	1.03	1.72	0.69	1.72	0.86	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	193.69	20.93	6.10	4.37	1.96	0.69	1.50	1.04	0.92	2.76
mesenchymal precursor cell - cardiac, donor3	11754-123G8	90.86	7.69	5.04	0.66	1.99	0.40	0.80	0.80	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	158.00	15.93	6.48	0.81	1.89	0.27	1.22	0.68	0.81	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	133.02	9.10	6.97	1.56	1.42	0.28	0.85	0.85	1.00	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	69.16	7.25	6.92	1.65	0.00	0.66	0.33	1.32	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	103.09	8.16	6.50	0.42	1.94	0.55	1.52	1.38	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	131.60	5.93	6.28	1.05	1.05	0.00	0.35	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	172.11	11.84	4.08	1.63	2.25	0.41	1.02	1.43	0.41	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	72.61	7.19	4.67	1.08	1.80	0.36	0.36	0.36	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	124.24	16.86	7.45	1.76	1.86	0.72	1.03	0.10	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	111.72	12.31	7.07	2.28	2.28	0.46	0.68	1.37	0.23	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	185.44	20.98	7.97	3.78	2.94	0.84	3.36	1.68	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	108.04	7.32	3.89	0.45	2.39	0.45	0.75	0.75	0.30	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	111.60	10.15	5.95	1.14	1.31	0.53	1.58	0.44	0.79	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	122.97	12.89	6.63	1.10	2.21	0.37	0.74	0.74	0.74	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	74.69	9.44	9.16	1.43	1.43	0.57	0.29	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	97.25	8.84	5.47	1.68	2.95	0.42	2.95	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	65.76	5.94	7.31	1.37	1.37	0.46	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	66.76	6.65	6.39	0.26	1.28	1.02	0.51	1.02	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	65.70	6.54	4.97	1.31	1.05	0.26	0.26	0.26	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	62.85	5.55	3.70	1.54	2.16	0.31	1.23	1.54	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	66.61	5.18	5.65	0.47	0.71	0.47	0.94	0.24	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	64.31	7.78	4.06	3.05	0.68	0.00	2.37	0.68	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	67.20	6.68	7.07	1.18	0.00	0.00	0.39	0.79	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	77.39	3.71	3.24	0.93	0.46	0.46	1.39	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	91.72	9.52	7.79	1.44	0.58	1.15	1.15	0.87	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	70.50	6.02	6.69	0.89	0.67	0.45	1.12	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.62	6.97	8.17	2.88	1.44	0.48	0.48	0.00	0.96	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	90.20	12.47	8.07	1.47	0.00	0.73	1.47	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	62.43	8.06	8.06	1.34	0.34	0.00	0.00	1.01	1.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	67.55	5.32	1.64	0.82	1.64	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	72.60	6.44	5.15	2.15	0.86	0.00	0.86	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	73.83	8.20	5.47	5.47	2.73	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	5.16	10.33	0.00	10.33	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	80.22	6.17	1.95	0.97	0.00	0.00	0.00	0.65	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	64.02	2.91	4.36	0.00	0.00	0.00	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	73.03	11.19	6.93	0.53	0.00	0.00	1.07	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	71.15	3.27	4.09	1.64	1.64	0.00	1.64	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	69.97	3.89	7.77	0.39	0.78	0.39	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	8.39	2.10	0.00	6.30	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	60.60	1.99	0.99	1.99	0.00	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	4.77	0.00	0.00	0.00	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	69.38	5.93	8.30	1.78	1.19	0.59	1.19	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	69.45	2.44	1.22	0.00	1.22	1.22	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	70.94	5.70	4.43	0.00	1.27	0.00	1.90	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	80.36	2.76	3.45	1.38	2.07	0.00	0.69	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	81.67	4.30	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	10.33	6.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	51.75	5.30	4.48	1.22	0.00	0.00	0.00	0.81	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	63.56	3.18	2.38	0.79	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	56.59	4.13	1.77	0.59	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	61.09	9.04	3.43	0.94	0.62	0.00	0.31	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	68.17	5.35	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	106.44	10.64	4.73	0.00	0.00	1.18	0.00	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	95.02	17.98	2.57	0.00	0.00	2.57	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	104.64	15.14	4.13	2.75	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	170.71	21.77	6.43	2.47	0.49	0.49	0.00	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	151.40	13.46	4.49	6.73	1.12	0.00	1.12	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	165.38	25.44	3.82	3.82	0.64	0.00	1.91	2.54	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	240.98	37.07	6.45	4.43	2.82	0.40	0.81	2.01	0.81	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	194.07	37.07	4.36	4.36	2.18	0.00	4.36	2.18	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	162.18	22.81	6.34	8.87	2.53	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	373.84	59.47	9.71	9.10	7.28	0.61	2.43	2.43	0.61	4.25
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	424.78	81.34	4.52	9.04	4.52	0.00	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	341.83	50.24	11.53	12.36	4.12	1.65	4.12	6.59	0.00	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	96.63	10.91	3.97	1.39	1.19	0.40	0.20	1.39	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	90.21	10.38	7.79	1.95	0.32	0.32	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	97.79	13.24	5.09	0.00	1.02	1.02	0.00	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	71.18	6.19	8.51	3.09	0.77	2.32	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	173.40	25.99	23.39	6.14	0.71	3.78	1.42	2.83	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	82.24	10.89	8.11	1.62	0.93	0.46	2.09	0.46	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	21.37	4.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	60.21	5.24	5.55	1.23	1.85	0.41	1.23	0.41	0.51	0.10
mesothelioma cell line:Mero-25	10850-111F4	21.56	13.39	6.35	0.45	0.68	0.00	0.00	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	67.72	5.87	6.11	0.24	0.98	1.22	1.22	0.73	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	96.10	7.97	4.43	1.11	3.54	0.89	0.89	0.66	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	70.43	17.87	9.20	0.79	2.37	1.05	1.84	0.53	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	75.24	8.85	8.68	1.87	1.70	1.02	0.85	0.68	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	29.32	2.02	3.03	0.00	0.51	0.76	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	63.98	11.59	9.52	1.86	1.24	0.62	1.66	0.62	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	54.17	7.29	4.64	1.49	0.99	0.66	0.33	0.17	0.17	0.33
mesothelioma cell line:NCI-H226	10846-111E9	93.75	11.76	5.43	0.72	1.27	0.72	0.90	1.09	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	87.46	8.03	6.32	1.20	1.02	0.85	1.02	0.68	0.68	0.34
mesothelioma cell line:NCI-H28	10845-111E8	56.75	6.11	10.43	1.27	0.76	1.78	0.76	0.51	1.27	0.25
mesothelioma cell line:No36	10857-111G2	24.47	7.50	7.18	1.30	0.98	0.65	0.33	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	68.55	6.50	5.96	0.54	1.35	2.98	0.27	0.00	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	113.62	4.22	4.41	0.77	2.49	0.19	2.30	1.73	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	95.49	4.76	5.74	0.98	2.32	0.61	1.34	0.61	0.73	0.00
migratory langerhans cells, donor3	11903-125F4	96.92	3.77	7.54	0.72	1.62	0.72	0.54	1.08	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	52.56	25.14	5.55	3.26	1.31	0.65	0.65	0.33	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	30.73	18.44	8.05	1.91	0.42	0.00	0.21	0.21	0.21	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	70.72	16.82	15.89	0.92	1.15	2.07	1.61	0.23	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.77	6.47	2.66	0.76	0.95	0.19	0.95	0.19	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	37.88	9.05	8.87	0.92	0.92	0.18	0.37	0.74	0.37	0.37
myeloma cell line:PCM6	10474-106I6	86.78	12.65	10.08	1.78	3.16	0.40	2.17	0.79	0.99	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	57.32	4.57	7.10	0.00	3.04	0.51	0.51	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	57.27	9.22	5.10	1.18	2.55	1.18	2.16	0.59	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	40.56	4.12	7.58	0.56	0.33	1.23	0.22	0.78	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	41.84	3.38	6.25	0.96	0.66	0.88	0.88	0.74	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	45.26	6.07	7.18	1.66	1.66	1.66	0.55	0.55	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	54.52	41.41	25.31	0.69	1.15	0.92	0.69	0.46	0.23	1.15
neuroblastoma cell line:NB-1	10539-107G8	62.49	34.98	15.72	2.25	1.31	1.12	0.94	0.75	0.37	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	35.43	26.57	14.76	1.48	1.48	1.27	0.21	0.84	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	17.14	24.97	13.98	1.30	0.19	0.93	0.19	0.19	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	37.48	8.07	12.81	0.24	0.47	0.47	0.00	0.24	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.24	12.99	9.82	1.11	0.63	0.48	0.16	0.32	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	21.53	12.48	13.28	0.60	0.20	1.01	0.00	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.35	2.54	9.54	0.64	0.00	1.91	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	89.70	18.90	10.65	1.33	0.80	1.33	1.06	0.27	0.27	0.27
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	90.99	33.82	15.05	2.03	1.18	0.51	0.17	0.85	0.17	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	104.07	28.82	12.81	0.80	1.60	2.40	0.00	1.60	2.40	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.43	10.26	9.62	0.64	2.56	0.96	0.32	0.00	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	56.23	5.26	6.31	0.79	0.53	1.31	0.79	0.53	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	46.96	17.53	16.12	1.97	0.75	3.09	0.47	1.22	0.28	0.37
occipital cortex - adult, donor10196	10172-103C1	26.78	14.42	26.78	2.06	0.00	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	70.85	24.42	26.03	1.07	1.34	1.88	0.81	0.81	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	55.32	17.11	15.65	2.55	0.00	4.37	0.36	1.82	0.73	0.73
occipital lobe, adult, donor1	10076-102A4	39.62	23.09	23.88	3.94	0.52	2.62	0.00	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	76.81	82.39	133.88	7.29	0.86	21.88	0.86	1.72	0.00	0.43
occipital pole, adult, pool1	10036-101E9	17.82	10.49	10.88	0.63	0.47	1.97	0.08	0.47	0.00	0.24
olfactory region, adult	10195-103E6	36.30	19.49	16.24	2.87	1.15	2.67	0.19	0.38	0.19	0.38
optic nerve, donor1	10277-104E7	66.03	60.03	80.04	4.00	0.00	12.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	85.54	13.67	12.42	1.94	3.87	1.94	2.05	0.57	1.14	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	22.26	8.38	8.38	0.55	0.41	0.96	0.27	0.55	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	53.34	5.42	7.28	1.02	0.68	0.00	1.52	0.51	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.93	6.58	5.89	0.69	1.27	0.35	0.81	0.23	0.58	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	86.13	14.11	13.52	2.65	2.94	0.59	0.88	1.76	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	61.67	14.02	2.80	1.87	0.00	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	57.26	11.03	13.36	0.85	1.48	1.06	1.91	0.21	0.42	0.00
ovary, adult, pool1	10020-101D2	49.97	18.96	13.80	1.92	0.52	1.75	0.96	0.61	0.26	0.61
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	63.61	13.38	11.37	0.55	0.37	1.65	0.00	0.92	0.00	0.37
pancreas, adult, donor1	10049-101G4	63.02	8.47	10.35	0.94	0.00	1.88	3.76	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.87	13.42	13.98	1.40	0.84	0.56	0.00	0.00	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	36.29	8.86	5.28	1.36	1.87	0.51	0.51	0.34	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	45.87	7.95	10.43	1.32	1.49	0.66	0.66	0.17	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	36.24	15.28	17.02	1.83	1.10	2.65	0.55	0.37	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	25.69	5.14	11.01	3.67	0.00	1.47	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	40.44	19.75	19.75	2.82	0.94	0.94	0.00	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	51.59	16.25	15.96	2.00	0.57	2.85	0.29	1.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	31.99	14.36	14.10	1.23	0.44	2.56	0.79	0.44	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	76.62	59.16	112.50	5.82	0.97	11.64	0.97	2.91	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	68.04	17.57	14.58	1.50	0.37	2.24	2.24	0.75	0.37	0.37
parotid gland, adult	10199-103F1	123.33	5.55	6.17	1.23	5.55	0.00	2.47	1.85	0.00	0.00
penis, adult	10200-103F2	104.74	23.63	14.50	4.30	2.69	0.00	1.61	1.61	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	27.89	5.02	10.78	1.49	0.19	2.23	0.19	1.12	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.44	8.01	6.56	0.58	1.17	0.87	1.46	0.58	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	49.02	16.77	12.90	0.00	0.65	5.16	0.65	0.00	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	62.77	15.99	20.14	0.59	2.37	4.15	0.59	0.00	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	51.42	10.03	9.41	0.63	0.63	2.51	1.25	0.00	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	98.14	27.32	31.37	2.02	3.04	5.06	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	116.74	23.45	28.14	0.52	4.69	3.65	2.61	0.00	1.04	2.08
pituitary gland, adult, donor10258	10378-105G9	91.08	14.47	16.17	1.70	1.70	1.70	3.40	0.85	0.85	0.85
placenta, adult, pool1	10021-101D3	80.30	8.71	8.60	1.61	2.26	2.47	2.37	0.54	0.75	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	49.79	10.59	7.02	1.19	0.26	0.40	0.26	0.26	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	98.36	12.45	11.21	1.56	3.58	0.93	3.27	0.31	1.25	0.00
pons, adult, pool1	10033-101E6	44.15	15.49	13.60	1.46	0.95	1.81	0.69	0.60	0.09	0.26
postcentral gyrus, adult, pool1	10032-101E5	21.88	14.12	14.56	1.22	0.52	2.44	0.61	0.26	0.09	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	8.37	29.28	0.00	2.09	0.00	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	5.51	11.02	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	34.67	4.81	5.24	1.60	0.44	0.44	0.73	0.44	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	60.80	9.26	8.17	0.73	0.91	0.73	1.45	1.09	0.00	0.00
prostate, adult, pool1	10022-101D4	71.10	12.15	13.24	2.00	1.36	1.09	1.90	0.45	0.82	0.18
putamen, adult, donor10196	10176-103C5	57.84	18.18	18.18	2.83	0.24	6.37	0.47	0.47	0.47	0.24
putamen, adult, donor10252	10152-102I8	64.70	3.92	27.45	3.92	0.00	1.96	0.00	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	34.97	8.74	7.65	2.19	0.00	0.00	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	37.93	9.91	14.26	1.21	0.48	3.14	0.48	0.48	0.72	0.24
putamen, newborn, donor10223	10365-105F5	69.72	27.74	12.74	4.50	1.50	3.00	1.50	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	55.86	11.64	8.15	1.75	0.29	0.87	1.75	0.58	0.87	0.29
rectum, fetal, donor1	10067-101I4	107.11	40.34	29.21	2.78	2.78	1.39	2.78	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	84.38	5.94	3.82	0.21	1.91	0.21	1.91	1.48	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	90.71	7.46	15.33	0.83	0.41	0.83	0.00	0.83	0.00	0.41
retina, adult, pool1	10030-101E3	45.52	12.42	15.21	0.40	1.29	1.59	1.09	0.70	0.50	0.10
retinoblastoma cell line:Y79	10475-106I7	5.72	10.39	6.75	0.52	0.78	1.30	0.00	0.52	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	104.38	63.07	18.20	6.02	0.49	1.60	0.49	2.58	0.00	3.81
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	56.52	31.21	14.62	1.41	0.56	0.56	0.56	0.84	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	77.30	12.13	11.37	0.76	0.00	0.00	0.00	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	48.07	9.39	9.55	0.81	1.13	0.65	0.49	0.32	0.32	0.16
salivary acinar cells, donor2	11772-123I8	42.68	8.54	6.20	0.83	1.65	0.83	0.41	0.14	0.41	0.14
salivary acinar cells, donor3	11773-123I9	55.61	21.19	12.58	1.99	0.66	2.65	1.32	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	94.94	5.15	9.15	1.14	1.14	1.14	2.29	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.42	10.54	8.52	1.52	1.52	1.43	0.42	0.84	0.08	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	57.25	7.99	9.52	2.00	1.41	1.18	0.59	0.94	0.12	0.12
seminal vesicle, adult	10201-103F3	96.82	15.87	13.23	0.53	2.65	2.65	1.06	0.53	1.06	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	70.21	7.53	9.96	0.49	2.92	0.49	0.97	0.73	1.70	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	30.95	2.77	3.27	0.00	0.50	0.25	0.25	0.25	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	2.01	5.02	2.01	0.00	0.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.72	5.64	6.72	0.54	0.27	0.67	0.27	0.00	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	41.12	3.09	4.20	0.66	0.88	0.33	0.66	0.33	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.74	1.68	4.26	0.13	1.29	0.39	0.90	0.26	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	214.22	36.18	33.34	0.71	2.84	2.84	1.42	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	299.24	36.10	20.99	6.00	3.24	1.92	3.96	2.76	1.92	0.60
skeletal muscle, fetal, donor1	10066-101I3	101.51	28.14	18.09	3.02	2.01	4.02	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	101.78	27.14	27.14	6.79	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	130.66	16.41	11.99	3.16	2.52	0.63	3.16	0.00	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.02	18.01	15.68	1.33	1.33	1.67	0.67	0.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	35.62	21.43	6.30	1.89	1.89	0.32	0.00	0.00	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	66.31	14.26	12.53	2.51	1.16	3.08	0.19	0.77	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	22.75	10.38	14.67	0.66	0.82	1.48	0.49	0.33	0.16	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	22.20	29.92	17.69	0.48	0.32	0.32	0.16	0.00	0.32	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	69.73	29.20	15.69	3.05	0.65	1.53	1.31	0.87	0.44	1.53
small intestine, adult, pool1	10024-101D6	112.04	13.14	13.02	1.91	6.33	1.55	6.81	0.36	2.99	0.00
small intestine, fetal, donor1	10064-101I1	65.85	15.97	16.22	0.98	0.98	2.46	1.97	0.49	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	87.71	9.75	5.64	2.05	1.54	0.51	1.54	0.51	2.05	1.54
smooth muscle, adult, pool1	10048-101G3	78.57	18.87	13.70	0.52	2.33	1.03	1.29	1.03	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	141.78	30.55	31.89	2.14	5.63	2.68	2.41	0.54	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	90.16	38.54	37.85	0.69	0.69	5.28	1.61	1.61	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	87.13	23.66	21.68	0.79	0.39	3.94	2.37	0.79	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	54.65	13.14	6.92	1.38	0.00	1.38	0.00	2.08	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	62.20	31.10	20.73	3.05	1.83	4.27	0.61	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	97.35	14.24	15.15	4.59	2.76	0.46	0.46	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	105.00	15.38	10.45	1.05	1.19	0.60	2.54	0.90	0.30	0.15
spleen, adult, pool1	10025-101D7	122.47	16.19	16.74	2.53	4.07	1.54	0.55	0.77	0.22	0.33
spleen, fetal, pool1	10044-101F8	76.12	15.26	14.78	1.11	0.64	1.75	0.87	0.56	0.00	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	31.16	3.21	3.52	0.41	0.52	0.52	0.62	0.31	0.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	61.14	12.91	10.25	1.52	1.14	0.95	0.95	0.76	0.76	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.51	6.64	9.44	1.40	1.05	2.10	0.35	1.05	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	73.10	12.12	7.04	0.00	0.00	0.00	1.56	0.39	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.76	13.06	13.84	1.24	2.93	1.46	3.26	0.00	1.58	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.11	5.51	2.54	0.85	0.42	0.85	0.85	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	82.92	5.08	2.54	1.27	0.42	0.42	0.85	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	70.49	28.84	22.43	1.07	2.14	2.14	0.00	2.14	0.00	0.00
submaxillary gland, adult	10202-103F4	102.54	6.27	17.66	1.71	1.14	0.57	0.57	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	54.27	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	73.74	21.19	18.28	1.25	0.42	2.28	0.83	0.21	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	40.35	9.83	7.76	0.52	0.52	0.52	0.52	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	89.74	24.73	14.13	2.12	0.00	2.12	0.00	0.71	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	35.54	5.73	5.04	1.15	0.23	0.46	0.23	0.92	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	20.26	11.02	10.43	0.76	0.34	2.29	0.34	0.59	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	68.38	56.27	99.72	12.11	0.71	26.35	0.71	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.06	25.93	45.27	3.96	0.00	9.23	0.00	2.20	0.00	0.44
tenocyte, donor1	11763-123H8	84.83	9.77	5.59	1.75	3.14	1.05	0.70	0.70	0.70	0.00
tenocyte, donor2	11765-123I1	78.21	8.39	4.96	0.76	0.38	0.38	0.00	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	94.15	10.01	3.71	1.11	1.85	0.37	0.37	1.48	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.93	40.28	26.17	1.36	0.51	2.21	0.51	1.53	0.17	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	39.62	31.14	11.25	1.70	0.77	0.31	0.62	0.46	0.46	1.23
teratocarcinoma cell line:PA-1	10807-111A6	28.98	17.98	18.13	0.93	0.15	1.86	0.00	0.15	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.53	8.89	9.01	1.27	0.89	0.51	0.76	0.76	0.25	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	34.04	26.47	16.26	3.40	0.00	0.76	0.38	0.38	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	60.09	11.78	10.58	2.40	1.74	1.31	1.20	0.22	0.11	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.45	8.79	8.79	1.63	0.00	1.95	0.00	0.00	0.00	0.65
testis, adult, pool1	10026-101D8	78.81	36.51	51.32	71.30	1.72	8.27	1.07	1.18	0.64	14.82
testis, adult, pool2	10096-102C6	48.27	63.15	75.78	110.97	0.45	14.43	0.45	4.06	0.90	42.40
thalamus - adult, donor10196	10168-103B6	66.24	30.91	25.39	2.21	1.10	4.42	2.21	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	65.95	19.54	19.69	0.78	0.94	2.97	1.41	0.63	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	9.24	6.16	0.00	0.00	3.08	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	25.36	17.95	22.56	0.82	0.49	4.45	0.49	0.66	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	50.05	10.36	9.78	2.30	0.00	0.58	0.58	0.58	0.00	1.15
throat, adult	10209-103G2	117.10	10.99	9.99	3.25	2.75	1.25	1.75	0.50	0.25	0.25
throat, fetal, donor1	10061-101H7	103.60	24.99	23.77	2.44	3.66	2.44	1.83	1.83	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	69.89	6.96	20.68	1.29	1.09	4.18	1.09	0.10	0.60	0.00
thymus, fetal, pool1	10043-101F7	81.15	13.51	19.95	1.66	1.35	1.45	1.25	0.94	0.31	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	57.17	7.98	5.19	1.20	1.33	0.93	0.80	0.00	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	52.94	13.83	11.59	1.68	0.98	1.54	0.84	1.54	0.70	0.42
thyroid, adult, pool1	10028-101E1	81.84	11.48	16.98	1.96	2.61	0.56	0.93	0.65	0.65	0.09
thyroid, fetal, donor1	10060-101H6	74.35	23.73	19.77	0.26	1.58	2.90	1.32	0.53	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	126.26	27.72	24.64	0.00	0.00	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	95.59	13.02	11.63	2.56	4.65	2.09	1.86	1.63	1.16	0.23
tongue, fetal, donor1	10059-101H5	129.66	35.86	20.49	1.58	3.15	2.36	2.76	1.18	0.00	0.00
tonsil, adult, pool1	10047-101G2	87.75	9.22	13.12	0.90	1.90	2.10	1.60	0.70	0.30	0.20
trachea, adult, pool1	10029-101E2	99.30	9.73	11.70	1.64	2.13	1.06	2.29	1.06	0.90	0.00
trachea, fetal, donor1	10058-101H4	82.32	19.62	16.54	1.54	1.54	2.31	1.92	0.77	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	82.19	11.34	8.15	2.83	1.06	0.71	0.35	1.42	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	45.19	9.52	10.74	1.11	1.72	0.81	0.91	0.30	0.81	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	100.28	20.37	21.62	4.54	0.78	1.57	1.25	1.88	1.10	0.63
tridermal teratoma cell line:HGRT	10694-109G1	76.10	15.22	17.12	0.00	1.90	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	54.26	11.26	10.58	1.44	1.61	1.19	0.42	0.51	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	50.08	14.61	14.61	2.09	2.09	2.09	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	85.83	17.57	19.45	1.37	2.56	1.19	2.39	0.17	0.68	0.17
uterus, fetal, donor1	10055-101H1	81.40	22.01	17.92	1.54	3.58	2.05	2.05	1.02	0.51	0.00
vagina, adult	10204-103F6	115.67	18.09	15.51	0.65	4.52	1.29	1.94	1.29	0.65	0.00
vein, adult	10191-103E2	83.73	18.41	12.71	1.32	1.75	1.75	0.22	0.66	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	44.33	4.27	3.74	0.80	0.27	0.27	0.27	0.80	0.53	0.27